Bewegung & Krebs

Ansprechpartner

Abteilungsleitung:
Prof. Dr. Hermann Brenner

E-Mail schreiben»

Publikationen

  • Bock JO, Heider D, Matschinger H, Brenner H, Saum KU, Haefeli WE, König HH. Willingness to pay for health insurance among the elderly population in Germany. European Journal of Health Economics 2016; 17:149-158.
  • Frank C, Fallah M, Chen T, Mai EK, Sundquist J, Försti A, Hemminki K. Search for familial clustering of multiple myeloma with any cancer. Leukemia 2016; 30(3):627-32.
  • Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, ..., Brenner H, Butterbach K, ..., Couch FJ, Spurdle AB, Goldgar DE. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate and ovarian cancers. Journal of the National Cancer Institute 2016; 108:djv315.
  • Lüthgens K, Albert S, Brenner H. Unterschiedliche Nachweisgrenzen immunologischer Tests auf Blut im Stuhl unterstreichen die Notwendigkeit der Standardisierung und Qualitätssicherung. Zeitschrift für Gastroenterologie 2016; 54(4):299-303.
  • Holleczek B, Brenner H. Implications from under-reporting, death certificate notifications and trace-back on the recorded incidence of a newly established population-based cancer registry. Methods of Information in Medicine 2016; 55(2):182-92.
  • Werner S, Krause F, Rolny V, Strobl M, Morgenstern D, Datz C, Chen H, Brenner H. Evaluation of a 5-marker blood test for colorectal cancer early detection in a colorectal cancer screening setting. Clinical Cancer Research 2016; 22(7):1725-33.
  • Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L., for the GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. European Journal of Cancer 2016; 52:102-108.
  • Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, ..., Brenner H, ..., Tomlinson I, Dowsett M, Easton DF, Spurdle AB. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocrine-Related Cancer 2016; 23:77-91.
  • Florath I, Butterbach K, Heiss JA, Bewerunge-Hudler M, Zhang Y, Schöttker B, Brenner H. Type 2 diabetes and leucocyte DNA methylation: An epigenome-wide association study in over 1500 older adults. Diabetologia 2016; 59:130-138.
  • Zhang Y, Schöttker B, Florath I, Stock C, Butterbach K, Holleczek B, Mons U, Brenner H. Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortality. Environmental Health Perspectives 2016; 124:67-74.
  • Carr PR, Jansen L, Walter V, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Association of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment. American Journal of Clinical Nutrition 2016; 103:192-200.
  • Mons U, Muscat JE, Modesto J, Richie JP, Brenner H. Effect of smoking reduction and cessation on the plasma levels of the oxidative stress biomarker glutathione - post-hoc analysis of data from a smoking cessation trial. Free Radical Biology & Medicine 2016; 91:172-177.
  • Müezzinler A, Mons U, Dieffenbach AK, Butterbach K, Saum KU, Schick M, Stammer H, Boukamp P, Holleczek B, Stegmaier C, Brenner H. Body mass index and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort. Experimental Gerontology 2016; 74:1-8.
  • Phipps A, Passarelli MN, Chan AT, Harrison TA, Jeon J, Hutter CM, Berndt SI, Brenner H, Caan BJ, Campbell PT, Chang-Claude J, Chanock SJ, Cheadle JP, Curtis KR, Duggan D, Fisher D, Fuchs CS, Gala M, Giovannucci EL, Hayes RB, Hoffmeister M, Hsu L, Jacobs EJ, Jansen L, Kaplan R, Kap L, Maughan TS, Potter JD, Schoen RE, Seminara D, Slattery ML, West H, White E, Peters U, Newcomb PA. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carciogenesis 2016; 37:87-95.
  • Carr P, Walter V, Brenner H, Hoffmeister M. Meat subtypes and their association with colorectal cancer: systematic review and meta-analysis. International Journal of Cancer 2016; 138:293-302.
  • Schöttker B, Saum KU, Jansen EHJM, Holleczek B, Brenner H. Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults. Age and Ageing 2016; 45:127-135.
  • Pattaro C, Teumer A, Gorski M, Chu AY, Li M, ..., Brenner H, ..., Butterbach K, ..., Köttgen A, Kao L, Fox CS. Genetic association at 53 loci highlight cell types and biologic pathways for kidney function. Nature Communications 2016; 7:10023.
  • Fallah M, Kharazmi E, Pukkala E, Tretli S, Olsen JH, Tryggvadottir L, Sundquist K, Hemminki K. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries. Leukemia 2016; 30(2):373-8.
  • Bock JO, Heider D, Matschinger H, Brenner H, Saum KU, Haefeli WE, König HH. Willingness to pay for health insurance among the elderly population in Germany. European Journal of Health Economics 2016; 17:149-158.
  • Boehlen F, Herzog W, Maatouk I, Saum K-U, Brenner H, Wild B. Behandlungswünsche von älteren Menschen mit psychischen Erkrankungen. Zeitschrift für Gerontologie und Geriatrie 2016; 49:120-125.
  • Lüthgens K, Albert S, Brenner H. Unterschiedliche Nachweisgrenzen immunologischer Tests auf Blut im Stuhl unterstreichen die Notwendigkeit der Standardisierung und Qualitätssicherung. Zeitschrift für Gastroenterologie 2016; 54:299-303.
  • Brenner H, Jansen L. Timely disclosure of progress in long-term cancer survival: The boomerang method substantially improved estimates in a comparative study. Journal of Clinical Epidemiology 2016;70:224-232.
  • Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, ..., Brenner H, Butterbach K, ..., Couch FJ, Spurdle AB, Goldgar DE. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate and ovarian cancers. Journal of the National Cancer Institute 2016; 108:djv315.
  • Holleczek B, Brenner H. Implications from under-reporting, death certificate notifications and trace-back on the recorded incidence of a newly established population-based cancer registry. Methods of Information in Medicine 2016; 55:182-192.
  • Werner S, Krause F, Rolny V, Strobl M, Morgenstern D, Datz C, Chen H, Brenner H. Evaluation of a 5-marker blood test for colorectal cancer early detection in a colorectal cancer screening setting. Clinical Cancer Research 2016; 22:1725-1733.
  • Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, ..., Dieffenbach AK, ..., Brenner H, ..., Butterbach K, ..., Böger CA, Fox CS, Pattaro C, Köttgen A. Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. Diabetes 2016; 65:803-817.
  • Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, ..., Brenner H, ..., Hoffmeister M, Butterbach K, ..., Hsu L, Chan A, Peters U, Chang-Claude J. CYP24A1 variant modifies the association between use of estrogen plus progestogen therapy and colorectal cancer. British Journal of Cancer 2016; 114:221-229.
  • Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, for the GEKID Cancer Survival Working Group. Survival from non-melanoma skin cancer in Germany. British Journal of Dermatology 2016; 174:713-714.
  • Petridis C, Brook MN, Shah V, Kohut K, Gorman P, ..., Brenner H, Arndt V, ..., Tomlinson I, Roylance R, Garcia-Closas M, Sawyer EJ. Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Research 2016; 18:22.
  • Kap EJ, Seibold P, Scherer D, Habermann N, Balavarca Y, Jansen L, Zucknick M, Becker N, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J. SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients. International Journal of Cancer 2016; 138:2993-3001.
  • Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining bowel cancer incidence and mortality in Germany - an analysis of time trends in the first ten years after the introduction of screening colonoscopy. Deutsches Ärzteblatt International 2016; 113:101-106.
  • Zhang Y, Florath I, Saum KU, Brenner H. Self-reported smoking, serum cotinine, and blood DNA methylation. Environmental Research 2016; 146:395-403.
  • Gdynia G, Sauer SW, Kopitz J, Fuchs D, Duglova K, Ruppert T, Miller M, Pahl J, Cerwenka A, Enders M, Mairlbäurl H, Kaminski MM, Penzel R, Zhang C, Fuller JC, Wade R Benner A, Chang-Claude J, Brenner H, Hoffmeister M, Zentgraf H, Schirmacher P, Roth W. The HMGB1 protein induces a metabolic type of tumor cell death by blocking aerobic respiration. Nature Communication 2016; 7:10764.
  • Florath I, Schöttker B, Butterbach K, Bewerunge-Hudler M, Brenner H. Epigenome-wide search for association of serum 25-hydroxyvitamin D concentration with leukocyte DNA methylation in a large cohort of older men. Epigenomics 2016; 8:487-499.
  • Schöttker B, Rathmann W, Herder C, Thorand B, Wilsgaard T, Njølstad I, Siganos G, Mathiesen EB, Saum KU, Peasey A, Feskens E, Boffetta P, Trichopoulou A, Kuulasmaa KK, Kee F, Brenner H. HbA1c levels in non-diabetic older adults - No J-shaped associations with primary cardovascular events, cardiovascular and all-cause mortality after adjustment for confounders. A meta-analysis of individual participant data from six cohort studies. BMC Medicine 2016; 14:26.
  • Chen H, Werner S, Butt J, Zörnig I, Knebel P, Michel A, Eichmüller SB, Jäger D, Waterboer T, Pawlita M, Brenner H. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget 2016; 7:16420-16432.
  • Chen T, Fallah M, Brenner H, Jansen L, Mai E, Castro F, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, for the GEKID Cancer Survival Working Group. Risk of second primary cancers in multiple myeloma survivors in German and Swedish cancer registries. Scientific Reports 2016; 6:22084.
  • Couch F, Kuchenbaecker K, Michailidou K, Mendoza-Fandino G, Nord S,..., Brenner H,..., Monteiro A, Garcia-Closas M, Easton D, Antoniou A. Identification of four novel susceptibility loci for estrogen receptor negative breast cancer. Nature Communications 2016; 7:11375.
  • Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, ..., Arndt V, Brenner H, ..., Chenevix-Trench G, Antoniou AC, Easton DF, Edwards SL. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics 2016; 48:374-86.
  • Chen X*, Schöttker B*, Castro F, Chen H, Zhang Y, Holleczek B, Brenner H. Association of Helicobacter pylori infection and chronic athrophic gastritis with risk of colonic, pancreatic and gastric cancer: a ten-year follow-up of the ESTHER cohort study. Oncotarget 2016; 7:17182-17193. *shared first authorship
  • Logan CA, Thiel L, Striebel S, Reister F, Brenner H, Rothenbacher D, Genuneit J. Delivery mode, duration of labor, and cord blood adiponectin, leptin, and C-reactive protein: Results of the population-based Ulm Birth Cohort Studies. PLoS ONE 2016; 11:e0149918.
  • Tsilidis KK, Papadimitriou N, Capothanassi D, Bamia C, Benetou V, Jenab M, Freisling H, Kee F, Nelen A, O’Doherty MG, Scott A, Soerjomataram I, Tjonneland A, May AM, Quirós JR, Pettersson-Kymmer U, Brenner H, Schöttker B, Ordónez-Mena J, Dieffenbach AK, Eriksson S, Bogeberg Mathiesen E, Njolstad I, Siganos G, Wilsgaard T, Boffetta P, Trichopoulos D, Trichopoulou A. Burden of cancer in a large consortium of prospective cohorts in Europe. Journal of the National Cancer Institute 2016; 108:djw127.
  • Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H for the GEKID Cancer Survival Working Group. Survival of elderly patients with multiple myeloma – Effect of upfront autologous stem cell transplantation. European Journal of Cancer 2016; 62:1-8.
  • Bock JO, Konig HH, Brenner H, Haefeli WE, Quinzler R, Matschinger H, Saum KU, Schöttker B, Heider D. Associations of frailty with health care costs? Results of the ESTHER cohort study. BMC Health Services Research 2016; 16:128.
  • Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Fecal immunochemical tests combined with other stool tests for colorectal cancer and advanced adenoma detection. A systematic review. Clinical and Translational Gastroenterology 2016; 7:e175.
  • Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V,…, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H. Minimally invasive colorectal cancer surgery in Europe: Implementation and outcomes. Medicine 2016; 95:e3812.
  • Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. Einführung eines organisierten Darmkrebs-Screenings in Deuschland: Chancen und Herausforderungen. Das Gesundheitswesen (in press).
  • Purrington KS, Slettedahl S, Bolla MK, ..., Brenner H, ..., Dieffenbach AK, Stegmaier C, Arndt V, ..., Slager S, Vachon CM, Couch FJ. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Human Molecular Genetics (in press).
  • von Winterfeld M, Hoffmeister M, Ingold-Heppner B, Jansen L, Tao S, Herpel E, Schirmacher P, Dietel M, Chang-Claude J, Autschbach F, Brenner H, Bläker H. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition. European Journal of Cancer (in press).
  • Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer - a systematic review. Medicine (in press).
  • Hollestelle A, van der Baan F, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, ..., Arndt V, ..., Brenner H, ..., Pharoah PDP, Rookus MA, Hooning MJ, Goode EL. No clinical utility of KRAS Variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology (in press).
  • Pulte D, Jansen L, Castro FA, Emrich K, Katathomic A, Holleczek B, Brenner H, for the GEKID Cancer Survival Working Group. Trends in survival of multiple myeloma patients in Germany and in the United States in the first decade of the 21st century. British Journal of Haematology (in press).
  • Hajek A, Bock JO, Brenner H, Saum KU, Matschinger H, Haefeli WE, Quinzler R, Heider D, König H-H. Welche Faktoren beeinflussen die privaten Zuzahlungen zu Gesundheitsleistungen im Alter? Ergebnisse einer Längsschnittstudie. Das Gesundheitswesen (in press).
  • Benner A, Hoffmeister M, Jansen L, Yang R, Bläker H, Herpel E, Ulrich A, Ulrich CM, Chang-Claude J, Brenner H, Burwinkel B. Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy. Genomics (in press).
  • Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ. Chronic kidney disease prevalence varies across European general population. Journal of the American Society of Nephrology (in press).
  • Sirri E, Castro F, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H for the GEKID Cancer Survival Group. Recent trends in survival of patients with pancreas cancer in Germany and the United States. Pancreas (in press).
  • O'Doherty MG, Cairns K, O'Neill V, Lamrock F, Jørgensen T, Brenner H, Schöttker B, Wilsgaard T, Siganos G, Kuulasmaa K, Boffetta P, Trichopoulou A, Kee F, on behalf of the CHANCES consortium. Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES). European Journal of Epidemiology (in press).
  • Easton DF, Lesueur F, Decker B, Michailidou K, Li J, ..., Arndt V, ..., Brenner H, ..., Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trenche G. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics (in press).
  • Zwink N, Stock C, Birkner B, Hoffmeister M, Brenner H. Screening colonoscopy volume and detection of colorectal neoplasms: A state-wide study from Bavaria, Germany. European Journal of Cancer Prevention (in press).
  • Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johannsson U, Tvedskof TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgois P, Moreau M, Mátrai Z, Sávolt A, Nagy P, Kásler M, Schrotz-King P, Ulrich C, Brenner H. Time trends in axilla management among early breast cancer patients: persisting major variation in clinical practice across European centers. Acta Oncologica (in press).
  • Dumstrei K, Chen H, Brenner H. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection. Oncotarget (in press).
  • Chen H, Knebel P, Brenner H. Empirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false positive findings. Journal of Clinical Epidemiology (in press).
  • Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, ..., Arndt V, ..., Brenner H, ..., Dunning AM, Antoniou AC, Easton DF, Cai Q, Long J. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer (in press).
  • Bull CJ, Bonilla C, Holly JMP, Perks CM, Davies N, Haycock P, Yu OHYY, Richards B, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, MacInnis RJ, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Michael A, Pandha H, and the PRACTICAL Consortium, Smith GD, Lewis SJ, Martin RM. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Medicine (in press).
  • Logan C, Zittel T, Striebel S, Reister F, Brenner H, Rothenbacher D, Genuneit J. Changing societal and lifestyle factors and breastfeeding patterns over time. Pediatrics (in press).
  • Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard B, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Panda H, Govindasami K, Muir K, COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative, The PRACTICAL consortium, Easton DF, Eeles RA, Kote-Jarai Z. Gene and pathway level analyses of germline DNA repair gene variants and prostate cancer susceptibility using the iCOGS genotyping array. British Journal of Cancer (in press).
  • Pulte D, Jansen L, Castro F, Brenner H. Changes in survival of older patients with hematologic malignancies in the early 21st century. Cancer (in press).
  • Koch-Gallenkamp L, Betram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Fear of recurrence in long-term cancer survivors - do cancer-type, sex, time since diagnosis, and social support matter? Health Psychology (in press).
  • Abubakar M, Orr N, Howat WJ, Daley F, Coulson P, Blows F, Ali HR, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, Martens JWM, Van Deurzen CHM, kConFab Investigators, Bolla MK, Wang Q, Jones M, Schoemaker M, Broeks A, Van Leeuwen FE, Van ´t Veer L, Easton D, Swerdlow AJ, Dowsett M, Pharoah PD, Schmidt MK, Garcia-Closas M. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays in the Breast Cancer Association Consortium (BCAC). Journal of Pathology: Clinical Research (in press).
  • Meid AD, Quinzler R, Groll A, Wild B, Saum K-U, Schöttker B, Heider D, König H-H, Brenner H, Haefeli WE. Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life. European Journal of Pharmacology (in press).
  • Ordonez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, O'Doherty MG, Scott A, Kee F, Stricker HB, Hofmann A, de Keyser CE, Ruiter R, Söderberg S, Jousilahti P, Kuulasmaa K, Freedman ND, Wilsgaard T, de Groot L, Kampman E, Håkansson N, Orsini N, Wolk A, Nilsson LM, Tjønneland A, Pajak A, Malyutina S, Kubínová R, Tamosiunas A, Bobak M, Katsoulis M, Oranos P, Boffetta P, Trichopoulou A, Brenner H. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Medicine (in press).
  • Schmidt M, Hogervorst F, van Hien R, Cornelissen S, Broeks A,..., Arndt V,..., Brenner H,..., Nevanlinna H, Dörk T, Bojesen S, Easton D. Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. Journal of Clinical Oncology (in press).
  • Walter V, Jansen L, Ulrich A, Roth W, Bläker H, Chang-Claude J, Hoffmeister M, Brenner H. Alcohol consumption and survival of colorectal cancer patients: population-based study from Germany. The American Journal of Clinical Nutrition (in press).
  • Dallmeier D, Brenner H, Mons U, Rottbauer W, Koenig W, Rothenbacher D. Growth Differentiation Factor 15, its 12-month relative change, and risk of cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA Study. Clinical Chemistry (in press).
  • Cheng THT, Thompson DJ, O’Mara TA, Painter JN, Glubb DM,…, Burwinkel B, Brenner H,…, Chang-Claude J,…, Edwards SL, Easton DF, Tomlinson I, Spurdle AB. Five endometrial cancer risk loci identified through genomewide association analysis. Nature Genetics (in press).
  • Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Smith GD,…, Brenner H,…, the PRACTIAL consortium, Lathrop M, Martin RM, Holly JMP. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: genetic variants as instruments for circulating levels. International Journal of Cancer (in press).
  • Brenner H, Jansen L, Ulrich A, Chang-Claude J, Hoffmeister M. Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget (in press).
  • Müezzinler A*, Mons U*, Dieffenbach AK, Butterbach K, Schick M, Schöttker B, Peasey A, De Vivo L, Trichopoulou A, Boffetta P, Brenner H. Leukocyte telomere length and all-cause, cardiovascular and cancer mortality: Results from individual participant data meta-analysis of two large prospective cohort studies. American Journal of Epidemiology (in press). *shared first authorship
  • Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A,..., Arndt V,..., Brenner H,..., Nevanlinna H, Dörk T, Bojesen S, Easton DF. Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. Journal of Clinical Oncology (in press).
  • Hajek A, Bock JO, Saum KU, Schöttker B, Brenner H, Heider D, König HH. Unterschiede in der Morbidität nach Krankenversichertenstatus im Alter. Das Gesundheitswesen (in press).
  • Gao X, Zhang Y, Breitling LP, Brenner H. Relationship of tobacco smoking and smoking-related DNA methylation with epigenetic age acceleration. Oncotarget (in press).
  • Winter A, Sirri E, Jansen L, Wawroschek F, Kieschke J, Castro FA, Krilaviciute A, Holleczek B, Emrich K, Waldmann A, Brenner H, for the GEKID Cancer Survival Working Group. Comparison of prostate cancer survival in Germany and the United States: Can differences be attributed to differences in stage distributions? BJU International (in press).
  • Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, for the GEKID Cancer Survival Working Group. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. International Journal of Cancer (in press).
  • Maatouk I, Herzog W, Böhlen F, Quinzler R, Löwe B, Saum KU, Brenner H, Wild B. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. Journal of Hypertension (in press).
  • Gao X, Zhang Y, Breitling L, Brenner H. Tobacco smoking and methylation of genes related to lung cancer development. Oncotarget (in press).
  • Brenner H, Kretschmann J, Stock C, Hoffmeister M. Expected long-term impact of screening endoscopy on colorectal cancer incidence: A modelling study. Oncotarget (in press).
  • Breitling LP, Saum KU, Schöttker B, Holleczek B, Herth FJ, Brenner H. Pneumonien in der nicht-institutionalisierten älteren Allgemeinbevölkerung: prospektive Beobachtungsstudie über 11 Jahre. Deutsches Ärzteblatt (in press).
  • Kar SP, Beesley J, Al Olama AA, Michailidou K, Tyrer J,..., Brenner H,…, Arndt V,…, Chenevix-Trench G, Eeles R, Pharoah PDP, Lambrechts D. Genome-wide meta-analyses of breast, ovarian and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types. Cancer Discovery (in press).
  • Mons U, Brenner H. Demographic ageing and the evolution of smoking-attributable mortality: the example of Germany. Tobacco Control (in press).

  • Lin W-Y, Camp NJ, Ghoussaini M, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Dunning A, Easton DF, Cox A. Identification and characterisation of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Human Molecular Genetics 2015; 24:285-298.
  • Campa D, Martino A, Varkonyi J, Lesueur F, Jamrozial K, Landi S, Jurczyszyn  A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, Garcia-Sanz R, Buda G, Gemignani F, Rios R, Vangsted AJ, Dumontet C, Martinez-Lopez J, Moreno MJ, Stepien A, Watek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SEH, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudzinski M, Weinhold N, Reis RM, Canzian F. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. International Journal of Cancer 2015:136:E351-E358.
  • Conway DI, Brenner DR, McMahon AD, Macpherson LMD, Agudo A, Ahrens W, Bosetti C, Brenner H, ..., Müller H, ..., Lee YCA, Hashibe M, Brennan P. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries.International Journal of Cancer 2015; 136:1125-1139.
  • Elgizouli M, Logan C, Nieters A, Brenner H, Rothenbacher D. Cord blood PRF1 methylation patterns and risk of lower respiratory tract infections in infants: findings from the Ulm Birth Cohort. Medicine 2015; 94:e332.
  • Glubb DM, Maranian MJ, Michailidou K, Pooley KA, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, .., Dunning AM, French JD. Fine scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. American Journal of Human Genetics 2015; 96:5-20.
  • Carvajal-Carmona L, O'Mara TA, Painter JN, ..., Brenner H, Dieffenbach AK, ..., Easton DF, Spurdle AB, Thompson DJ. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human Genetics 2015; 134:231-245.
  • Rudolph A, Milne RL, Truong T, ..., Dieffenbach AK, Arndt V, Stegmaier C, ..., Brenner H, ..., Pharoah PDP, Garcia-Closas M, Chang-Claude J. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. International Journal of Cancer 2015; 136:E685-E696.
  • GBD 2013 Mortality and Causes of Death Collaborators*. Global, regional and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385:117-171. *Collaborators from DKFZ: Brenner H, Schöttker B.
  • Brenner H, Hoffmeister M, Birkner B, Stock C. Which adenomas are detected by fecal occult blood testing? A state-wide analysis from Bavaria, Germany. International Journal of Cancer 2015; 136:1672-1679.
  • Ashwin N, Ananthakrishnan AN, Du M, Berndt SI, Brenner H, Caan BJ, Casey G, Chang-Claude J, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hou L, Hsu L, Jenkins MA, Kraft P, Ma J, Nan H, Newcomb PA, Ogino S, Potter JD, Seminara D, Slattery ML, Thornquist M, White E, Wu K, Peters U, Chan AT. Red meat intake, NAT2, and risk of colorectal cancer: A pooled analysis of 11 studies. Cancer Epidemiology, Biomarkers and Prevention 2015; 24:198-205.
  • Dallmeier D, Pencina MJ, Rajman I, Koenig W, Rothenbacher D, Brenner H. Serial measurements of N-Terminal Pro-Brain Natriuretic Peptide in patients with coronary heart disease. PLoS One 2015; 10:e0117143.
  • Braig S, Brandt S, Wabitsch M, Florath I, Brenner H, Rothenbacher D, Genuneit J. Age-specific influence of wheezing phenotypes on preadolescent and adolescent health-related quality of life. Pediatric Allergy and Immunology 2015; 25:781-787.
  • Stock C, Uhlmann L, Hoffmeister M, Laux G, Kieser M, Brenner H. Identification of physicians with unusual performance in screening colonoscopy databases: a Bayesian approach. Gastrointestinal Endoscopy 2015; 81:646-654.
  • Kabisch M, Lorenzo Bermejo J, Dünnebier T, Ying S, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Hamann U. Inherited variants in the inner contromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER negative breast cancer. Carcinogenesis 2015; 36:256-271.
  • Painter JN, O'Mara TA, Batra J, ..., Brenner H, Dieffenbach AK, ..., Edwards SL, Thompson DJ, Spurdle AB. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human Molecular Genetics 2015; 24:1478-1492.
  • Yang R, Pfütze K, Zucknick M, Sutter C, Wappenschmidt B, Marma F, Qu B, Cuk K, Engel C, Schott S, Schneeweiss A, Brenner H, Claus R, Plass C, Bugert P, Hoth M, Sohn C, Schmutzler R, Bartram CR, Burwinkel B. DNA methylation array analyses identified breast cancer associated HYAL2 methylation in peripheral blood. International Journal of Cancer 2015; 136:1845-1855.
  • Bläker H, Hildebrandt B, Riess H, von Winterfeld M, Ingold-Heppner B, Roth W, Kloor M, Schirmacher P, Dietel M, Tao S, Jansen L, Chang-Claude J, Ulrich A, Brenner H, Hoffmeister M. Lymph node count and prognosis in colorectal cancer: the influence of examination quality. International Journal of Cancer 2015; 136:1957-1966.
  • Bickeböller M, Tagscherer K, Kloor M, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Toth C, Schirmacher P, Roth W, Bläker H. Functional characterization of the tumor suppressor MARCKS in colorectal cancer and its association with survival. Oncogene 2015; 34:1150-1159.
  • Bozorgmehr K, San Sebastian M, Brenner H, Razum O, Maier W, Saum KU, Holleczek B, Miksch A, Szecsenyi J. Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008 - 2010. International Journal for Equity in Health 2015; 14:28.
  • Jansen L, Castro F, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H for the GEKID Cancer Survival Workgroup. Recent cancer survival in Germany: an analysis of common and less common cancers. International Journal of Cancer 2015; 136:2649-2658.
  • Allemani C, Weir HK, ..., Tucker TC, Coleman MP, Concord Working Group*. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,877 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet 2015; 385:977-1010. *Member of the CONCORD Working Group from DKFZ: Brenner H.
  • Heiss JA, Brenner H. Between-array normalization for 450K data. Frontiers in Genetics 2015; 6:92.
  • Brandt S, Moß A, Koenig W, Rothenbacher D, Brenner H, Wabitsch M. Intrafamilial  associations of cardiometabolic risk factors - results of the Ulm Birth Cohort Study. Atherosclerosis 2015; 240:174-183.
  • Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, haarrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman J, Peters U Hsu L, Chan AT; for the CCFR and GECCO. Association of Aspirin and NSAID use with risk of colorectal cancer according genetic variants. JAMA 2015; 313:1133-1142.
  • Michailidou K, Beesley J, Lindstrom S, Canisius S, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Hall P, Easton DF. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics 2015; 47:373-381.
  • Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Standford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeria MR, Consortium P, Bioresource AP, Spurdle AB, Clements JA, Park JY, Batra J. A large scale analysis of genetic variants within putative miRNA binding sites in prostate cancer. Cancer Discovery 2015; 5:368-379.
  • Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clinical Gastroenterology and Hepatology 2015; 13:717-723.
  • Emrich IE, Pickering J, Schöttker B, Lennartz CS, Rogacev KS, Brenner H, Rothenbacher D, Holleczek B, Saum KU, Fliser D, Heine GH. Comparison of the performance of two GFR Estimating Equations using creatinine and cystatin C to predict adverse outcomes in elderly individuals. Americal Journal of Kidney Diseases 2015; 65:632-638.
  • Schöttker B, Saum KU, Jansen EHJM, Boffetta P, Trichopoulou A, Holleczek B, Dieffenbach AK, Brenner H. Oxidative stress markers and all-cause mortality at older age. A population-based cohort study. Journal of Gerontology: Medical Sciences 2015; 70:518-524.
  • Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K: Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology 2015; 24(1): 40-6.
  • Scharhag-Rosenberger F, Kuehl R, Klassen O, Schommer K, Schmidt ME, Ulrich CM, Wiskemann J, Steindorf K: Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations. Journal of Cancer Survivorship 2015; 137(2):471-80.
  • Scharhag-Rosenberger F, Wiskemann J, Scharhag J: Cardiopulmonary exercise testing in cancer patients: should we really refrain from considering it for preparticipation screening? Oncologist 2015; 20(2): 228.
  • Ungar N, Sieverding M, Ulrich CM, Wiskemann J (2015): What explains the intention to be physically active in cancer patients? Different determinants for active and insufficiently active patients. J Psychosoc Oncol. 33(1):15-33
  • Werner S, Chen H, Tao S, Brenner H. Systematic Review: Serum autoantibodies in the early detection of gastric cancer. International Journal of Cancer 2015; 136:2243-2252.
  • Rothenbacher D, Jaensch A, Mons U, Hahmann H, Becker T, Koenig W, Brenner H. Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: role of physical activity and unmet medical need. European Journal of Preventive Cardiology 2015; 22:1129-1138.
  • Chen H, Chen XZ, Waterboer T, Castro FA, Brenner H. Viral infections and colorectal cancer: a systematic review of epidemiological studies. International Journal of Cancer 2015; 137:12-24.
  • Vart P, Bakker SJL, Schöttker B, de Zeeuw D, Rothenbacher D, Brenner H, Lambers Heerspink HJ, Saum KU, Reijneveld SA, Bültmann U, Koenig W, Gansevoort RT. Relevance of correction for drift and day-to-day variation in cystatin C measurement: a post-hoc analysis of the PREVEND cohort, with independent replication in the ESTHER cohort. Clinical Chemistry and Laboratory Medicine 2015; 53:1381-1390.
  • Perna L, Wahl HW, Mons U, Saum KU, Holleczek B, Brenner H. Cognitive impairment, all-cause and cause-specific mortality among non-demented older adults. Age and Ageing 2015; 44:445-451.
  • Boehlen F, Herzog W, Quinzler R, Haefeli WE, Maatouk I, Niehoff D, Saum KU, Brenner H, Wild B. Loneliness in the elderly is associated with the use of psychotropic drugs. International Journal of Geriatric Psychiatry 2015; 30:957-964.
  • Song M, Gong J, Giovannucci EL, ..., Brenner H, Chang-Claude J, ..., Hoffmeister M, ..., Jensen M, Peters U, Chan AT. Genetic variants of adiponectin and risk of colorectal cancer. International Journal of Cancer 2015; 137:154-164.
  • Orr N, Dudbridge F, Dryden N, ..., Brenner H, Dieffenbach AK, Arndt V, ..., dos Santos Silva I, Fletcher O, Peto J. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Human Molecular Genetics 2015; 24:2966-2984.
  • Benetou V, Orfanos P, Feskanich D, Michaelsson K, Pettersson-Kymmer U, Ahmed L, Peasey A, Wolk A, Brenner H, Bobak M, Wilsgaard T, Schöttker B, Saum KU, Bellavia A, Grodstein F, Klinaki E, Valanou E, Papatesta HM, Boffetta P, Trichopoulou A. Education, marital status and risk of hip fractures in older men and women: the CHANCES project. Osteoporosis International 2015; 26:1733-1746.
  • Kap EJ, Seibold P, Richter S, Scherer D, Habermann N, Balavarca Y, Jansen L, Becker N, Pfuetze K, Popanda O, Hoffmeister M, Ulrich A, Benner H, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer. The Pharmacogenomics Journal 2015; 15:505-512.
  • Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, de Groot L, Freedman ND, Jansen E, Kee F, Kromhout D, Kuulasmaa K, Laatikainen T, O'Doherty MG, Bueno-de-Mesquita B, Orfanos P, Peters A, van der Schouw YT, Wilsgaard T, Wolk A, Trichopoulou A, Bofetta P, Brenner H, on behalf of the CHANCES consortium. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults - Meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. British Medical Journal 2015; 350:h1551.
  • Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, Nishihara R, Ogino S, Prentice RL, Schumacher FR, Seminara D, Slattery ML, Thomas DC, Thornquist M, Newcomb PA, Potter JD, Zheng Y, White E, Peters U on behalf of the Colorecal Transdisciplinary (CORECT) Study and Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology 2015; 148:1330-1339.
  • Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. Journal of the National Cancer Institute 2015; 107:djv045.
  • Saum KU, Dieffenbach AK, Jansen EHJM, Schöttker B, Holleczek B, Hauer K, Brenner H. Association between oxidative stress and frailty in an elderly German population: results from the ESTHER cohort study. Gerontology 2015; 61:407-415.
  • Pulte D, Jansen L, Brenner H. Survival disparities by insurance type for patients age 15-64 with Non-Hodgekin Lymphoma. The Oncologist 2015; 20:554-561.
  • Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H. Smoking and survival of colorectal cancer patients: population-based study from Germany. International Journal of Cancer 2015; 137:1433-1445.
  • Brenner H, Jansen L. Restriction to period of interest improves informative value of death certificate only proportions in period analysis of cancer survival. Journal of Clinical Epidemiology 2015; 68:1432-1439.
  • Zhang Y, Schöttker B, Ordonez-Mena J, Holleczek B, Yang R, Burwinkel B, Butterbach K, Brenner H. F2RL3 methylation, lung cancer incident and mortality. International Journal of Cancer 2015; 137:1739-1748.
  • Guo Q, Schmidt MK, Kraft P, Canisius S, ..., Brenner H, Dieffenbach AK, Arndt V, ..., Pharoah PDP. Identification of novel genetic markers of breast cancer survival. Journal of the National Cancer Institute 2015; 107:djv081.
  • Müezzinler A, Gellert C, Mons U, Schöttker B, Jansen E, Kee F, O'Doherty MG, Kuulasmaa K, Freedman ND, Abnet CC, Wolk A Håkansson N, Orsini N, Wilsgaard T, Njølstad I, Bøgeberg M, Leenders M, Bueno-de-Mesquita B, van der Schouw YT, Peeters PH, Streppel MT, de Groot LCPGM, Peters A, Schneider A, Orfanos P, Linneberg A, Pisinger C, Lorbeer R, Tamosiunas A, Baceviciene M, Luksiene D, Bernotiene G, Jousilahti P, Schaan B, Wennberg P, Petterson-Kymmer U, Jansson JH, Söderberg S, Eriksson S, jankovic N, Kromhout D, Geelen A, Sánchez M-J, Veronesi G, Trichopoulou A, Boffetta P, Brenner H. Smoking and all-cause mortality in older adults - Results from CHANCES Consortium. American Journal of Preventive Medicine 2015; 49:e53-e63.
  • Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary S, Capurso G, Bas Bueno-de-Mesquita H, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Hassan M, Greenhalf W, Pasquali C, Hackert T, Fuchs C, Mohelníková-Duchoñová B, Sperti C, Funel N, Dieffenbach AK, Wareham NJ, Buring J, Holcátová I, Costello-Goldring E, Zambone C-F, Kupcinskas J, Risch HA, Kraft P, Bracci PM, Pezzilli R, Olson SH, Sesso H, Hartge P, Strobel O, Malecka-Panas E, Visvanathan K, Arslan AA, Pedrazzoli S, Sucek P, Gioffreda D, Key TJ, Talar-Wojnarowska R, Scarpa A, Mambrini A, Jacobs EJ, Jamroziak K, Klein A, Tavano F, Bambi F, Landi S, Austin MA, Vodickova L, Brenner H, Chanock SJ, Delle Fave G, Piepoli A, Cantore M, Zheng W, Wolpin B, Amundadottir L, Canzian F. The TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. International Journal of Cancer 2015; 137:2175-2183.
  • Chen H, Zucknick M, Werner S, Brenner H. Head-to head comparison and evaluation of 92 plasma protein biomarkers for early detection of colorectal cancer in a true screening setting. Clinical Cancer Research 2015; 21:3318-3326.
  • Brenner H, Altenhofen L, Stock C, Hoffmeister M. Expected long-term impact of the German screening colonoscopy program on colorectal cancer prevention: analyses based on 4,407,971 screening colonoscopies. European Journal of Cancer 2015; 51:1346-1353.
  • Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer - a systematic review. Medicine 2015; 94(20):e792.
  • Al Olama AA, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal D, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman C, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler -Johnson C, Habuchi T, Thibodeau SN, Cooney K, Chappius PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF. Risk analysis of prostate cancer in PRACTICAL, a multinational consortium, using 25 unknown prostate cancer susceptibility loci. Cancer Epidemiology, Biomarkers and Prevention 2015; 24:1121-1129.
  • Darabi H, McCue K, Beesley J, Michailidou K, ..., Brenner H, ..., Arndt V, ..., Dunning AM, Easton DF, Hall P, Cevenix-Trench G. Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 expression. American Journal of Human Genetics 2015; 97:22-34.
  • Schumacher F, Schmit S, Jiao S, Edlund C, Wang H, ..., Butterbach K, ..., Brenner H, ... Hoffmeister M, ..., Casey G, Gruber S, Peters U. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature Communication 2015; 6:7138.
  • Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, ..., Brenner H, Butterbach K, Arndt V, ..., Fasching PA, Pharoah PDP, Schmidt MK. Common germline polymorphisms associated with breast cancer specific survival. Breast Cancer Research 2015; 17:58.
  • Global Burden of Disease Study 2013 Collaborators*. Global, regional, and national incidence, prevalence, and YLDs for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Diseases Study 2013. The Lancet 2015; 386:743-800. *Collaborators from DKFZ: Brenner H, Schöttker B.
  • Brenner H, Altenhofen L, Kretschmann J, Rösch T, Pox C, Stock C, Hoffmeister M. Trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program. Gastroenterology 2015; 149:356-366.
  • Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M. Overexpression of SIX1 is an independent prognostic marker in stage I - III colorectal cancer. International Journal of Cancer 2015; 137:2104-2113.
  • Beyerle J, Frei E, Stiborova M, Habermann N, Ulrich CM. Biotransformation of xenobiotics in the human colon and rectum and its associations with colorectal cancer. Drug Metab Rev 2015; 47(2):199-221.
  • Wiskemann J, Kleindienst N, Kuehl R, Dreger P, Schwerdtfeger R, Huber G, Bohus M. Effects of a physical exercise on survival after allogeneic stem cell transplantation. International Journal of Cancer 2015; 137(11):2749-56.
  • Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K: Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. International Journal of Cancer 2015; 137(2), 471-480.
  • Gollhofer SM, Wiskemann J, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Hof H, Potthoff K, Steindorf K (2015): Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy. BMC Cancer, 15(1):186.
  • Skender S, Schrotz-King P, Böhm J, Abbenhardt C, Gigic B, Chang-Claude, J, Siegel EM, Steindorf, K, Ulrich, CM. Repeat physical activity measurement by accelerometry among colorectal cancer patients—feasibility and minimal number of days of monitoring. BMC Research Notes 2015; 8:222.
  • Kharazmi E, Fallah M, Pukkala E, Olsen JH, Tryggvadottir L, Sundquist K, Tretli S, Hemminki K. Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries. Blood 2015; 126(17): 1990-5.
  • Kharazmi E, Hemminki K, Pukkala E, Sundquist K, Tryggvadottir L, Tretli S, Olsen JH, Fallah M. Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries. Eur Urol 2015; 68(2):283-9.
  • Frank C, Fallah M, Sundquist J, Hemminki A, Hemminki K. Population Landscape of Familial Cancer. Sci Rep 2015; 5:12891.
  • Chen T, Fallah M, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki H, for the GEKID Cancer Survival Working Group. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Letters 2015; 369:152-166.
  • Brenner H. Colorectal cancer screening for older adults. BMJ 2015; 350:h2029.
  • Schöttker B, Brenner H. Vitamin D as a resilience factor, helpful for survival of potentially fatal conditions. A hypothesis emerging from recent findings of the ESTHER cohort study and the CHANCES consortium. Nutrients 2015; 7:3264-3278.
  • Sobral-Leite M, Wesseling J, Smit V, Nevanlinna H, van Miltenburg MH, ..., Brenner H, Butterbach K, Arndt V, Holleczek B, ..., García-Closas M, de Graauw M, Schmidt MK. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis. BMC Medicine 2015; 13:156.
  • Darabi H, McCue K, Beesley J, Michailidou K, ..., Brenner H, ..., Arndt V, ..., Dunning AM, Easton DF, Hall P, Cevenix-Trench G. Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 expression. American Journal of Human Genetics 2015; 97:22-34.
  • Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, Pers TH, Gallinger S, Hayes RB, Baron JA, Caan BJ, Ogino S, Berndt SI, Chanock SJ, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lindor NM, Seminara D, Song M, Wu K, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT. Mendelian randomization study of body mass index and colorectal cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2015; 24:1024-1031.
  • Schöttker B, Zhang Y, Heiss JA, Butterbach K, Jansen EHJM, Bewerunge-Hudler M, Saum KU, Holleczek B, Brenner H. Discovery of a novel epigenetic cancer marker related to the oxidative status of human blood. Genes Chromosomes and Cancer 2015; 54:583-594.
  • Gondos A, Krilaviciute A, Smailyte G, Ulys A, Brenner H. Cancer surveillance using registry data: results and recommendations for the Lithuanian national prostate cancer early detection programme. European Journal of Cancer 2015; 51:1630-1637.
  • Brenner H, Altenhofen L, Kretschmann J, Rösch T, Pox C, Stock C, Hoffmeister M. Trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program. Gastroenterology 2015; 149:356-366.
  • Müezzinler A, Mons U, Dieffenbach AK, Butterbach K, Saum KU, Schick M, Stammer H, Boukamp P, Holleczek B, Stegmaier B, Brenner H. Smoking habits and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort. Experimental Gerontology 2015; 70:18-25.
  • Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, ..., Brenner H, Butterbach K, Stegmaier C, ..., the PRACTICAL consortium, Gronberg H, Wiklund F. Prediction of individual genetic risk to prostate cancer using a polygenic score. The Prostate 2015; 75:1467-1474.
  • Freigofas J, Seidling HM, Quinzler R, Schöttker B, Saum KU, Brenner H, Haefeli WE. Characteristics of medication schedules used by elderly ambulatory patients. European Journal of Clinical Pharmacology 2015; 71:1109-1120.
  • Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins MG, Li D, Neale R, Olson SH, Scelo G, Bamlet WR, Bijlsma M, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F. Capurso G, Cavestro GM, Chaffee KG, Cleary SP, Cotterchio M, Foretova L, Funel N, Gazouli M, Hassan M, Holcatova I, Holly EA, Janout V, Key TJ, Kupcinskas J, Kurtz RC Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Strobel O, Tavano F, Vashist YK, Vodicka P, Yu H, Petersen GM, Risch H, Klein AP. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nature Genetics 2015; 47:911-916.
  • Candido do Reis FJ, Lynn S, Ali HR, Eccles D, Hanby A, Provenzano E, Caldas C, Howqat WJ, McDuffus LA, Liu B, Daley F, Coulson P, Vyas RJ, Harris LM, Owens JM, Carton AFM, McQuillan JP, Paterson AM, Hirji Z, Christie SK, Holmes AR, Schmidt MK, Garcia-Closas M, Easton DF, Bolla MK, Wang Q, Benitez J, Milne RL, Mannermaa A, couch F, Defilee P, cox A, Cross SS, Blows FM, Sanders J, de Groot R, Figueroa J, Sherman M, Hooning M, Brenner H, Holleczek B, Stegmaier C, Lintott C, Pharoah PDP for the Citizen Science Alliance. Croudsourcing the general public for large scale molecular pathology studies in cancer. EBioMedicine 2015; 2:681-689.
  • Meid AD, Quinzler R, Feigofas J, Saum K-U, Schöttker B, Holleczek B, Heider D, König H-H, Brenner H, Haefeli WE. Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS One 2015;10:e0136339.
  • Surinova S, Choi M, Tao S, Schüffler PJ, Chang CY, Clough T, Vyslouzil K, Khoylou M, Srovnal J, Liu Y, Matondo M, Hüttenhain R, Weisser H, Buhmann JM, Hajdúch M, Brenner H, Vitek O, Aebersold R. Prediction of colorectal cancer diagnosis based on circulating plasma proteins. EMBO Molecular Medicine 2015; 7:1166-1178.
  • Surinova S, Radová L, Choi M, Srovnal J, Brenner H, Vitek O, Hajdúch M,  Aebersold R. Non-invasive prognostic protein biomarker signatures associated with colorectal cancer. EMBO Molecular Medicine 2015; 7:1153-1165.
  • Khalili H, Gong J, Brenner H, Austin TR, Hutter CM, Baba Y, Baron JA, Berndt SI, Bézieau S, Caan B, Campbell PT, Chang-Claude J, Chanock SJ, Chen C, Hus L, Jiao S, Conti DV, Duggan D, Fuchs CS, Gala M, Gallinger S, Haile RW, Harrison TA, Hayes R, Hazra A, Henderson B, Haiman C, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Küry S, LaCroix A, le Marchand L, Lemire M, Lindor NM, Ma J, Manson JE, Morikawa T, nan H, Ng K, Newcomb PA, Nishihara R, Potter JD, Qu C, Schoen RE, Schumacher FR, Seminara D, Taverna D, Thibodeau S, Wactawski-Wende J, White E, Wu K, Zanke BW, Casey G, Hudson TJ, Kraft P, Peters U, Slattery ML, Ogino S, Chan AT on behalf of GECCO and CCFR. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carciogenesis 2015; 36:999-1007.
  • Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kin C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach AK, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Heinrich H, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis - a meta-analysis. Journal of the National Cancer Institute 2015; 107:djv100.
  • Rothenbacher D, Dallmeier D, Mons U, Rosamond W, Koenig W, Brenner H. Sexual activity patterns before myocardial infarction and risk for subsequent cardiovascular adverse events. JACC 2015; 66:1516-1517.
  • Brenner H. Mortality from malignant melanoma in an era of nationwide skin cancer screening. Deutsches Ärzteblatt 2015; 112:627-628.
  • Anderson LA, Tavilla A, Brenner H, Luttmann S, Navaro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon f, Sant M, EUROCARE-5 Working Group. Survival for oesophageal, stomach and small intestine cancers: results from EUROCARE-5. European Journal of Cancer 2015; 51:2144-2157.
  • Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, Hackl M, Eisemann N, Brenner H, and the EUROCARE-5 Working Group. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe - results from the EUROCARE-5 study. European Journal of Cancer 2015; 51:2158-2168.
  • Gao X, Jia M, Zhang Y, Breitling LP, Brenner H. DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies. Clinical Epigenetics 2015; 7:113.
  • Brenner H, Stock C, Hoffmeister M. Colorectal cancer screening: the time to act is now. BMC Medicine 2015; 13:262.
  • Bozorgmehr K, Maier W, Brenner H, Saum KU, Stock C, Miksch A, Holleczek B, Szecsenyi J, Razum O. Social disparities in Disease Management Programmes for coronary heart disease in Germany: A cross-classified multilevel analysis. Journal of Epidemiology & Community Health 2015; 69:1091-1101.
  • Galeone C, Turati F, Zhang ZF, Guerico V, Tavani A, Serraino D, Brennan P, Fabianova E, Lissowska J, Mates D, Rudnai P, Shangina O, Szeszenia-Dabrowska N, Vaughan TL, Kelsey K, McClean M, Levi F, Hayes RB, Purdue MP, Bosetti C, Brenner H, Pelucchi C, Lee YCA, Hashibe M, Boffetta P, La Vecchia C. Relation of allium vegetables intake with head and neck cancers: evidence from the INHANCE Consortium. Molecular Nutrition and Food Research 2015; 59:1641-1650.
  • Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, for the GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and the United States. Journal of Gastroenterology and Hepatology 2015; 30:1485-1491.
  • Perna L, Mons U, Rujescu D, Kliegel M, Brenner H. Apolipoprotein E e4 and cognitive function: a modifiable association? Results from two independent cohort studies. Dementia and Geriatric Cognitive Disorders 2015; 41:35-45.
  • Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, ..., Arndt V, ..., Brenner H, ..., Murabito JM, Perry JRB, Murray A. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nature Genetics 2015; 47:1294-1303.
  • Imhof A, Koenig W, Jaensch A, Mons U, Brenner H, Rothenbacher D. Long-term prognostic value of lgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease. Atherosclerosis 2015; 243:414-420.
  • Lemire M, Qu C, Loo LWM, Zaidi SHE, Wang H, Berndt SI, Bézieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Du M, Edlund CK, Gallinger S, Haile RW, Harrision TA, Hoffmeister M, Hopper JL, Hou L, Hsu L, Jacobs EJ, Jenkins MA, Jeon J, Küry S, Li L, Lindor NM, Newcomb PA, Potter JD, Rennert G, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Severi G, Slattery ML, White E, Wood MO, Cotterchio M, Le Marchand L, Casey G, Gruber SB, Peters U, Hudson TJ. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Human Genetics 2015; 134:1249-1262.
  • Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, ..., Arndt V, ..., Brenner H, ..., Dunning AM, Easton DF, Zheng W. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention 2015; 24:1680-1691.
  • Brenner H, Altenhofen L, Stock C, Hoffmeister M. Vorsorge-Koloskopie in Deutschland - Bilanz und Perspektiven. Endoskopie heute 2015; 28:174-177.
  • Krilaviciute A, Heiss JA, Leja M, Kupcinskas J, Haick H, Brenner H. Detection of cancer through exhaled breath: a systematic review. Oncotarget 2015; 6:38643-38657.
  • Pfütze K, Benner A, Hoffmeister M, Jansen L, Yang R, Bläker H, Herpel E, Ulrich A, Ulrich CM, Chang-Claude J, Brenner H, Burwinkel B. Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy. Genomics 2015; 106:348-354.
  • Eberle A, Jansen L, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, for the GEKID Cancer Survival Working Group. Lung cancer survival in Germany: a population-based analysis of 132,612 lung cancer patients. Lung Cancer 2015; 90(3):528-533.
  • Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. Einführung eines organisierten Darmkrebs-Screenings in Deuschland: Chancen und Herausforderungen. Das Gesundheitswesen 2015; 77(11):869-74.

  • Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P. (2014), “Potential of fecal microbiota for early-stage detection of colorectal cancer”. Mol Syst Biol, 2014. 10(11): p. 766.
  • Liesenfeld DB, Habermann N, Toth R, Owen RW, Frei E, Böhm J, Schrotz-King P, Klika KD,  Ulrich CM (2014), “Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare)”. Metabolomics, 2014, Vol. 10, Nr. 6. DOI 10.1007/s11306-014-0758-3
  • Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann N. (2014), “Suitability of Circulating miRNAs as Potential Prognostic Markers in Colorectal Cancer”. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23(12): 2632-7. PMID: 25472670
  • Schmid D, Steindorf K, Leitzmann MF (2014): Epidemiologic Studies of Physical Activity and Primary Prevention of Cancer. Dt. Zeitschrift für Sportmedizin, 65, 5-10.
  • Klassen O, Schmidt ME, Scharhag-Rosenberger F, Sorkin M, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K*, Wiskemann J* (2014): Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy. Acta Oncologica, 53, 1356-65. *Shared last authorship
  • Wiskemann J, Steindorf K (2014): Resistance training as supportive therapy in Oncology [in German]. Dt. Zeitschrift für Sportmedizin, 65, 22-24.
  • Wientzek A, Vigl M, Steindorf K, Brühmann B, Bergmann MM, Harttig U, Katzke V, Kaaks R, Boeing H (2014): The Improved Physical Activity Index for measuring physical activity in EPIC Germany. PLos One, 9, e92005, epub only.
  • Steindorf K, Schmidt ME, Wiskemann J, Ulrich CM (2014). Physiologic and molecular mechanisms linking endurance and resistance training with effects for cancer patients. Dt. Zeitschrift für Sportmedizin, 65, 299-303.
  • Brühmann B, Schmidt ME, Steindorf K (2014): Assessment of physical activity in epidemiological studies: Are questionnaires obsolete in the era of accelerometry? GMS Medizinische Informatik, Biometrie und Epidemiologie, 10(1). doi:10.3205/mibe000155.
  • Steindorf K*, Schmidt ME*, Klassen O, Ulrich CM, Oelmann J, Habermann N, Beckhove P, Owen R, Debus J, Wiskemann J, Potthoff K (2014): Randomized Controlled Trial of Resistance Training in Breast Cancer Patients Receiving Adjuvant Radiotherapy: Results on Cancer-related Fatigue and Quality of Life. Annals of Oncology, 25, 2237-43. *Shared first authorship
  • Scharhag-Rosenberger F, Becker T, Streckmann F, Schmidt K, Berling A, Bernardi A, Engeroff T, Exner AK, Gutekunst K, Hofmeister D, Jensen W, Kähnert H, Kneis S, Limbach M, Mau-Möller A, Röcker K, Schmidt ME, Schmidt T, Stöckel T, Wehrle A, Wiskemann J, Zimmer P, Zopf E, Steindorf K (2014). Studien zu körperlichem Training bei onkologischen Patienten: Empfehlungen zu den Erhebungsmethoden. Dt. Zeitschrift für Sportmedizin, 65, 304-313.
  • Steindorf K, Schmidt ME, Scharhag-Rosenberger F, Wiskemann J (2014): Supportive Sport- und Bewegungstherapie für onkologische Patienten. Onkologie Heute, 9, 41-46.
  • Schmidt ME, Wiskemann J, Steindorf K (2014). Exercise in breast cancer patients: impact on health. Breast Cancer Management 3:241–250.
  • Kuehl R, Scharhag-Rosenberger F, Schommer K, Dreger P, Bohus M, Wiskemann J (2014). Exercise intensity classification in cancer patients undergoing allogeneic HSCT. Medicine & Science in Sport and Exercise; epub ahead of print
  • Wiskemann J, Scharhag-Rosenberger F (2014). Nebenwirkungsorientierte Behandlungspfade für die bewegungstherapeutische Betreuung onkologischer Patienten. Bewegungstherapie und Gesundheitssport 30(4), 146-150
  • Huebner J, Marienfeld S, Abbenhardt C, Ulrich CM, Muenstedt K, Micke O, Muecke R., Loeser C. Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Research 2014;34,39-48.
  • Stiborová M, Frei E. Ellipticines as DNA-targeted chemotherapeutics, Current Med. Chem. 2014;21,575-591.
  • Wiskemann J, Steindorf K (2014). Standards der Sportmedizin: Krafttraining als Supportivtherapie bei onkologischen Patienten [Resistance training as supportive therapy for cancer patients. Deutsche Zeitschrift für Sportmedizin, 65(1): 22-24.
  • Klassen O, Schmidt ME, Scharhag-Rosenberger F, Sorkin M, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K*, Wiskemann J* (2014): Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy. Acta Oncologica, 53, 1356-65. *Shared last authorship
  • Wientzek A, Vigl M, Steindorf K, Brühmann B, Bergmann MM, Harttig U, Katzke V, Kaaks R, Boeing H (2014): The Improved Physical Activity Index for measuring physical activity in EPIC Germany. PLos One, 9, e92005.
  • Steindorf K*, Schmidt ME*, Klassen O, Ulrich CM, Oelmann J, Habermann N, Beckhove P, Owen R, Debus J, Wiskemann J, Potthoff K (2014): Randomized Controlled Trial of Resistance Training in Breast Cancer Patients Receiving Adjuvant Radiotherapy: Results on Cancer-related Fatigue and Quality of Life. Annals of Oncology, 25, 2237-43. *Shared first authorship
  • Brühmann, BA, Schmidt, ME, Wientzek A, Vigl M, Teucher B, Katzke VA, Boeing H, Bergmann MM, Kaaks R, Steindorf K (2014): Reliability and validity of the Questionnaire on Annual Physical Activity Pattern: A validation study using combined heart rate and accelerometry data as an objective measurement. World Journal of Epidemiology and Cancer Prevention, 3, 51-63.

Books

  • Baumann FT, Wiskemann J (2014). Sport- und Bewegungstherapie. In: Heim R, Weis J eds. Fatigue bei Krebserkrankungen, 154-165. Stuttgart: Schattauer Verlag.

Sonstige Schriften

  • Löser C, Arends J, , Steindorf K, Scheppach W, Staffa J, Ulrich CM, Wiskemann J, Riemann JF (2014). Prävention und Therapie von Dickdarmkrebs – Plädoyer für einen gesunden Lebensstil - Frankfurter Erklärung der Stiftung Lebensblicke.

  • Vrieling A, Buck K, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer 2013, 108, 188-192.
  • Ritte R, Lukanova A, Tjonneland A, Olsen A, Overvad K, Mesrine S, Fagherazzi G, Dossus L, Teucher B, Steindorf K, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Quiros JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita B, van Duijnhoven F, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Krum-Hansen S, Gram IT, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, McCormack V, Riboli E, Kaaks R. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: A cohort study. Int J Cancer 2013, 132, 2619-2629.
  • Elena J, Travis L, Simonds N, Ambrosone C, Ballard-Barbash R, Bhatia S, Cerhan J, Hartge P, Heist R, Kushi L, Lash T, Morton L, Onel K, Pierce J, Robison L, Rowland J, Schrag D, Sellers T, Seminara D, Shu XO, Thomas N, Ulrich CM, Freedman A. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst 2013;105:85-94.    
  • Wang H, Taverna D, Stram D, Chang I, Wilkens L, Burnett T, Makar KW, Lindor NM, Hopper JL, Gallinger S, Baron J, Haile R, Kolonel L, Henderson BE, Newcomb P, Duggan D, Ulrich CM, Le Marchand L. Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2013;22:2094-2101.
  • Carvalho AL, Annoni R, Torres LH, Durao AC, Shimada AL, Almeida FM, Hebeda CB, Lopes FD, Dolhnikoff M, Martins MA, Silva LF, Farsky SH, Saldiva PH, Ulrich CM, Owen RW, Marcourakis T, Trevisan MT, Mauad T. Anacardic acids from cashew nuts ameliorate lung damage induced by exposure to diesel exhaust particles in mice. Evid Based Complement Alternat Med 2013, 2013, 549879.    
  • Villaseñor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multi-ethnic cohort of breast cancer survivors. Cancer Causes and Control 2013;24:759-767
  • Cadmus-Bertram L, Littman A, Ulrich CM, Stovall R, Ceballos R, McGregor B, Wang CY, Ramaprasad J. Predictors of adherence to a 26-week Viniyoga yoga intervention among post-treatment breast cancer survivors. The Journal of Alternative and Complementary Medicine 2013;19:751-758.
  • Zschäbitz S, Cheng T-YD, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Bailey LB, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM. B vitamin intakes and incidence of colorectal cancer: Results from the Women’s Health Initiative Observational Study Cohort. American Journal of Clinical Nutrition 2013;97:332-343.
  • Seufert BL, Poole EM, Whitton J, Xiao L, Makar KM, Campbell PT, Kulmacz RJ, Baron JA, Newcomb PA, Slattery ML, Potter JD, Ulrich CM. IkBKb and NFkB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2013;34:79-85.
  • Mason C, Foster-Schubert KE, Imayama I, Xiao L, Kong A, Campbell KL, Duggan CR, Wang CY, Alfano CM, Ulrich CM, Blackburn GL, McTiernan A. History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism 2013;62:127-136.        
  • Barry EL, Poole E, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control 2013;24:47-54.
  • Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Bette Caan, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML. PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes & Nutrition 2013;8:115-126.
  • Miller JW, Ulrich CM. Folic acid and cancer- where are we today? The Lancet 2013;381: 974-976.
  • Zschäbitz S, Cheng T-YD, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Bailey LB, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM. B vitamin intakes and incidence of colorectal cancer: Results from the Women’s Health Initiative Observational Study Cohort. American Journal of Clinical Nutrition 2013;97:332-343.
  • Campbell K, Foster-Schubert K, Makar K, Kratz M, Hagman D, Schur E, Habermann N, Horton M, Abbenhardt C, Kuan L, Xiao L, Davison J, Morgan M, Wang C, Duggan C, McTiernan A, Ulrich CM. Gene-expression changes in adipose tissue with diet- and/or exercise-induced weight loss. Cancer Prevention Research (Phila) 2013;6:217-231.
  • Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush S, Makar KW, Würtele G, Haubner R, Sellers TA, Grady W. Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. Journal of Nutritional Science 2013;2:1-6.
  • Abbenhardt C, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Toriola AT, Potter JD, Mason C, Xiao L, Blackburn GL, Bain C, Ulrich CM. Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med 2013;274:163-175.
  • Potthoff K, Schmidt M, Wiskemann J, Hof H, Klassen O, Habermann N, Beckhove P, Debus J, Ulrich CM, Steindorf K. Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: The BEST Study. BMC Cancer 2013;13:162.
  • Strasser B, Steindorf K, Wiskemann J, Ulrich CM. Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 2013;45:2080-2090.
  • Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanow D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM. Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study. Pharmacogenet Genomics 2013;23:428-437.
  • Miller JW, Beresford SAA, Neuhouser ML, Cheng TY, Song X, Brown EC, Zheng Y, Rodriguez B, Green R, Ulrich CM. Homocysteine, cysteine and risk of incident colorectal cancer in the Women’s Health Initiative Observational Cohort. Am J Clin Nutr 2013;97:827-834.    
  • Abbenhardt C, Poole E, Xiao L, Curtin K, Galbraith R, Duggan D, Hsu L, Makar K, Kulmacz R, Potter J, Caan B, Koepl L, Coghill A, Muehling J, Taverna D, Carlson C, Slattery M, Ulrich CM. Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. International Journal of Molecular Epidemiology and Genetics 2013;4:140-149.
  • Liu AY, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Molecular Nutrition and Food Research 2013;57:721-734.
  • Toriola AT, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013;132:2648-2658.
  • Kleinstein SE, Heath L, Makar KW, Poole EM, Seufert BL, Slattery ML, Xiao L, Duggan DJ, Hsu L, Curtin K, Heath L, Koepl L, Muehling J, Taverna D, Caan B, Carlson CS, Potter JD, Ulrich CM. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes, Chromosomes and Cancer 2013;52:437-449.
  • Sherwood AM, Emerson O, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jäger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM, Robins H; dual senior authorship. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol Immunother 2013;62:1453-1461.
  • De Souza JRR, Feitosa JPA,  Ricardo NMPS, Trevisan MTS,  de Paula HCB, Ulrich CM, Owen RW. (2013). Spray-drying encapsulation of mangiferin using natural polymers. Food Hydrocolloids. 2013;33: 10-18.
    Steindorf K, Wiskemann J, Schmidt ME, Ulrich CM. Mechanismen zum Benefit von Kraft- und Ausdauertraining bei Krebspatienten. Sportmedizinische Nachrichten 2013;9:13.
  • Ulrich CM, Miller JW. Folate and health: present and future. Mol Nutr Food Res 2013, 57, 561.
  • Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study). Contemp Clin Trials 2013, 34, 117-125.    
  • Stiborová M, Dracinska H, Martinek V, Svaskova D, Hodek P, Milichovsky J, Hejdukova Z, Brotanek J, Schmeiser HH, Frei E. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein and enzyme activity levels in rats exposed to the carcinogenic azo dye  1-phenylazo-2-naphthol (Sudan I). Chem Res Toxicol 2013;26(2):290-9.
  • Steindorf K, Eomois PP, Ritte R, Lukanova AK, Fønns Johnsen N, Tjønneland A, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Boutron-Ruault M-C, Schulz M, Boeing H, Teucher B, Rohrmann S, Trichopoulou A, Kalapothaki V, Koliva M, Krogh V, Palli D, Tumino R, Panico S, Monninkhof E, Peeters PH, Boshuizen HC, Bueno-de-Mesquita HB, Chirlaque M-D, Agudo A, Larrañaga N, Quirós JR, Martínez C, Barricarte A, Janzon L, Berglund G, Bingham S, Khaw KT, Key TJ, Norat T, Jenab M, Cust A, Wahrendorf J, Riboli E, Kaaks R. Physical Activity and Risk of Breast Cancer Overall and by Hormone Receptor Status: The European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer 2013;132:1667-78.
  • Wiskemann J, Steindorf K. Sports and exercise therapy in Oncology [in German: Sport- und Bewegungstherapie in der Onkologie]. Der Klinikarzt 2013;42:402-5.
  • Schmidt ME, Chang-Claude J, Vrieling A, Seibold P, Heinz J, Flesch-Janys D, Steindorf K. Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer. International Journal of Cancer 2013;133:1431-40.
  • Bock C, Schmidt ME, Vrieling A, Chang-Claude J, Steindorf K. Walking, bicycling, and sports in postmenopausal breast cancer survivors-results from a German patient cohort study. Psychooncology 2013;22:1291-8.
  • Steindorf K, Schmidt K. Körperliche Aktivität für onkologische Patienten in Deutschland: derzeitige Arbeitsschwerpunkte und gemeinsame Ziele. FORUM 2013;28:436-8.
  • Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control 2013;24,47-54.
  • Liu AY, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res 2013;57,721-734.
  • Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM,  Caan B, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML. PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr 2013;8,115-126.
  • Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013;132,2648-2658.    
  • Steindorf K, Ritte R, Eomois PP, Lukanova A, Tjonneland A, Johnsen NF, Overvad K, Ostergaard JN, Clavel-Chapelon F, Fournier A, Dossus L, Teucher B, Rohrmann S, Boeing H, Wientzek A, Trichopoulou A, Karapetyan T, Trichopoulos D, Masala G, Berrino F, Mattiello A, Tumino R, Ricceri F, Quiros JR, Travier N, Sanchez MJ, Navarro C, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Duijnhoven F, Monninkhof E, May AM, Khaw KT, Wareham N, Key TJ, Travis RC, Borch KB, Sund M, Andersson A, Fedirko V, Rinaldi S, Romieu I, Wahrendorf J, Riboli E, Kaaks R. Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition. Int J Cancer 2013;132,1667-1678.
  • Schneider S, Yamamoto S, Weidmann C, Brühmann B. Sports injuries among adolescents: Incidence, causes and consequences. J Paediatr Child Health 2012;48,E183-189.
  • Buck K, Hug S, Seibold P, Ferschke I, Altevogt P, Sohn C, Schneeweiss A, Burwinkel B, Jäger D, Flesch-Janys D, Chang-Claude J. Marme, F. CD24 polymorphisms in breast cancer: impact on prognosis and risk. Breast Cancer Res Treat 2013;137,927-937.    
  • Maccioni L, Rachakonda PS, Scherer D, Bermejo JL, Planelles D, Requena C, Hemminki K, Nagore E, Kumar R. Variants at chromosome 20 (ASIP locus) and melanoma risk. Int J Cancer 2013;132,42-54.
  • Mason C, Foster-Schubert KE, Imayama I, Xiao L, Kong A, Campbell KL, Duggan CR, Wang CY, Alfano CM, Ulrich CM, Blackburn GL, McTiernan A. History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism 2013;62,127-136.
    Maccioni L, Rachakonda PS, Scherer D, Bermejo JL, Planelles D, Requena C, Hemminki K, Nagore E, Kumar R. Variants at chromosome 20 (ASIP locus) and melanoma risk. Int J Cancer. 2013;132:42-54
  • Ritte R, Lukanova AK, Tjønneland A, Olsen A, Overvad K, Mesrine S, Fagherazzi G, Dossus L, Teucher B, Steindorf K, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita B, van Duijnhoven F, van Gils CH, Peeters PH, Wareham N, Khaw TK, Key TJ, Travis RC, Krum-Hansen S, Torhild Gram I, Lund E,  Sund M, Andersson A, Romieu-I, Rinaldi S, McCormack V, Riboli E, Kaaks R. Height, age at menarche and risk of hormone receptor positive and negative breast cancer: A cohort study. International Journal of Cancer 2013;132:2619-29.
  • Zeeb H, Bickeböller H, Jöckel KH, Stang A, Stark K, Steindorf K, Swart E, Waldmann A: Das Zertifikat „Epidemiologie“ der Fachgesellschaften DGEpi, GMDS, DGSMP und IBS-DR: Aktualisierung 2013. GMS Medizinische Informatik, Biometrie und Epidemiologie 2013;9:1-5.
  • Poljaková J, Eckschlager T, Kizek R, Frei E, Stiborová M. Electrochemical Determination of Enzymes Metabolizing Ellipticine in Thyroid Cancer Cells - a Tool to Explain the Mechanism of Ellipticine Toxicity to these Cells. Int. J. Electrochem. Sci. 2013;8:1573-85.
  • Vranová I, Moserová M, Hodek P, Kizek R, Frei E, Stiborová M. The Anticancer Drug Ellipticine Induces Cytochromes P450 1A1, 1A2 and 3A, Cytochrome b5 and NADPH:Cytochrome P450 Reductase in Rat Liver, Kidney and Lung. Int. J. Electrochem. Sci 2013;8:1586-97.
  • Stiborová M, Martínek V, Frei E, Arlt VM, Schmeiser HH. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer. Curr Drug Metab 2013;14(6):695-705.
  • Hodek P, Koblihova J, Kizek R, Frei E, Arlt V.M, Stiborová M. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rats. Environ. Toxicol. Pharmacol. 2013;36(3):989-96.
  • Pedrolli DB, Jankowitsch F, Schwarz J, Langer S, Nakanishi S, Frei E, Mack M. Riboflavin analogs as antiinfectives: occurrence, mode of action, metabolism and resistance. Curr Pharm Des. 2013;19(14):2552-60.
  • Scharhag-Rosenberger F, Meyer T. Steigerung der Ausdauerleistungsfähigkeit: Ergometrische Erfassung und Zusammenhänge mit präventiven Trainingseffekten. Deutsche Zeitschrift für Sport¬medizin, 2013;64(2):45-51
  • Steindorf K, Wiskemann J (2013). Chapter 13: Physical activity and cancer – primary and tertiary prevention. In Löser C (ed): Nutrition in Modern Oncology. Unimed Science, Bremen. 110-115.
  • Liesenfeld DB, Habermann N, Owen RW, Scalbert A, Ulrich CM. Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiol Biomarkers Prev 2013;22,2182-2201.    
  • Indra R, Moserova M, Sulc M, Frei E, Stiborová M. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 – a comparative study. Neuro Endocrinol. Lett 2013;34,55-63.
  • Bae S, Ulrich CM, Bailey LB, Malysheva O, Brown EC, Neuhouser, M, Cheng T-YD, Miller JW, Zheng Y, Xiao L, Hou L, Song X, Buck K, Beresford AA, Caudill MA. Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women's Health Initiative Observational Study cohort. Epigenetics 2013, 9.
  • Makar KW, Poole EM, Resler AJ, Seufert B, Curtin K, Kleinstein SE, Duggan D, Kulmacz RJ,Hsu L, Whitton J, Carlson CS, Rimorin CF, Caan BJ, Baron JA, Potter JD, Slattery ML, Ulrich CM. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control 2013;24,2059-2075.
    Stiborová M, Cerna V, Moserova M, Arlt VM, Frei E. The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice. Neuro Endocrinol. Lett. 2013;34,43-54.    
  • Carlsohn A, Scharhag-Rosenberger F, Heydenreich J, Mayer F. Vitamin D-Status von Spitzenathleten mit hoher UV-Exposition im Training. Ernährungsumschau 2013;60,174-176.
  • Kantor ED, Ulrich CM, Owen RW, Schmezer P, Neuhouser ML, Lampe JW, Peters U, Shen DD, Vaughan TL, White E. Specialty supplement use and biologic measures of oxidative stress and DNA damage. Cancer Epidemiol Biomarkers Prev 2013;22,312-2322.
  • Scharhag-Rosenberger F, Schommer K. Standards der Sportmedizin: Spiroergometrie in der Sportmedizin. Deutsche Zeitschrift für Sportmedizin 2013;64,362-366.
  • Baumann F, Steindorf K. Bewegungsangebote im Versorgungsalltag. FORUM 2012, 29, in press.
  • Scharhag-Rosenberger F. Aktiv leben nach Krebs mit gesundheitsorientiertem Fitnesstraining. Public Health Forum 2013; 21(2):19.e1-19.e3
  • Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bezieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T, Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia WH, Kolonel LN, Kooperberg C, Kury S, Lacroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu XO, Slattery ML, Taverna, D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng Y X, Zhang B, Zheng W, Hsu L. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 2013;144,799-807 e724.   

  • Rampoldi, F., Sandhoff, R., Owen, R. W., Grone, H. J., Porubsky, S., A new, robust, and nonradioactive approach for exploring N-myristoylation. J Lipid Res 2012;53:2459-2468.
  • Amann PM, Luo C, Owen RW, Hofmann C, Freudenberger M, Schadendorf D, Eichmuller SB, Bazhin AV. Vitamin A metabolism in benign and malignant melanocytic skin cells: importance of lecithin/retinol acyltransferase and RPE65. J Cell Physiol 2012;227:718-28.
  • Haug U, Poole EM, Xiao L, Curtin K, Duggan D, Hsu L, Makar KW, Peters U, Kulmacz RJ, Potter JD, Koepl L, Caan BJ, Slattery ML, Ulrich CM. Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer 2012;51:598-605.
  • Huy C, Schmidt ME, Vrieling A, Chang-Claude J, Steindorf K. Physical activity in a German breast cancer patient cohort: One-year trends and characteristics associated with change in activity level. Eur J Cancer 2012;48:297-304
  • Liedtke S, Schmidt ME, Vrieling A, Lukanova A, Becker S, Kaaks R, Zaineddin AK, Buck K, Benner A, Chang-Claude J, Steindorf K. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012;20:1088-1095.
  • Schneider S, Diehl K, Brühmann B. Do boys suffer injury more often than girls in sport? Gesundheitswesen 2012;74:234-235.
  • Steindorf K, Baumann F. AG Körperliche Aktivität forciert Kooperation der Grundlagenforschung mit der Versorgungsforschung. FORUM 2012;27:226.
  • Schmidt ME, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern. J Cancer Surviv 2012;6:11-19.
  • Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: Design and rationale of a randomized controlled trial (BEATE study). Contemp Clin Trials 2012;34,117-125.
  • Steindorf K, Ritte R, Tjonneland A, Johnsen NF, Overvad K, Ostergaard JN, Clavel-Chapelon F, Fournier A, Dossus L, Lukanova A, Chang-Claude J, Boeing H, Wientzek A, Trichopoulou A, Karapetyan T, Trichopoulos D, Masala G, Krogh V, Mattiello A, Tumino R, Polidoro S, Quiros J R, Travier N, Sanchez M J, Navarro C, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Duijnhoven FJ, Monninkhof E, May AM, Khaw KT, Wareham N, Key TJ, Travis RC, Borch K B, Fedirko V, Rinaldi S, Romieu I, Wark PA, NoratT, Riboli E, Kaaks R. Prospective study on physical activity and risk of in situ breast cancer. Cancer Epidemiol Biomarkers Prev 2012;21,2209-2219.
  • Steindorf K, Schmidt M, Ulrich CM. Welche Effekte hat körperliche Bewegung auf das Krebsrisiko und auf den Krankheitsverlauf nach einer Krebsdiagnose? Bundesgesundheitsblatt 2012;55:10-16.
  • Stiborova M, Eckschlager T, Poljakova J, Hrabeta J, Adam V, Kizek R, Frei E. The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment. Curr Med Chem 2012;19,4218-4238.
  • Stiborova M, Indra R, Moserova M, Cerna V, Rupertova M, Martinek V, Eckschlager T, Kizek R, Frei E. Cytochrome b5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases. Chem Res Toxicol 2012;25,1075-1085.
  • Stiborova M, Poljakova J, Eckschlager T, Kizek R, Frei E. Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the (3)(2)P-postlabeling technique. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012;156,115-121.
  • Stiborova M, Poljakova J, Martinkova E, Ulrichova J, Simanek V, Dvorak Z, Frei E. Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b(5). Toxicology 2012;302,233-241.
  • Sudjaroen Y, Hull WE, Erben G, Würtele G, Changbumrung S, Ulrich CM, Owen RW. Isolation and characterization of ellagitannins as the major polyphenolic components of Longan (Dimocarpus longan Lour) seeds. Phytochemistry 2012;77,226-237.
  • Ulrich CM, Steindorf K. Krebsprävention durch Lebensstil – was ist evidenzbasiert? Der Onkologe 2012;18,192-197.
  • Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP. Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women. Epigenetics 2012;7,1020-1028.
  • Ulrich CM, Wiskemann J, Steindorf K. Physiologic and molecular mechanisms linking physical activity to cancer risk and progression. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55,3-9.
  • Wiskemann J, Klassen O, Steindorf K. Sport bei Krebserkrankten. Forum Onkologische Pflege 2012;2,14-17.
  • Wiskemann J, Kühr L, Kühl R. Evidenzbasierte Trainingsprogramme für Krebspatienten. Onkologische Pharmazie 2012;14,20-23.
  • Wiskemann J. Effects of exercise on psychosocial outcomes in patients undergoing hematopoietic stem cell transplantation. Die Psychiatrie 2012;9,209-214.
  • Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 2012;72,2314-2326.
  • Liu W, Poole EM, Ulrich CM, Kulmacz RJ. Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1. Pharmacogenet Genomics 2012; 22,525-537.    
    Kizek R, Adam V, Hrabeta J, Eckschlager T, Smutny S, Burda JV, Frei E, Stiborova M. Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances. Pharmacol Ther 2012;133,26-39.
  • Levova K, Moserova M, Nebert DW, Phillips DH, Frei E, Schmeiser HH, Arlt VM, Stiborova M. NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I. Toxicol Appl Pharmacol 2012;265,360-367.
  • Littman AJ, Bertram LC, Ceballos R, Ulrich CM, Ramaprasad J, McGregor B, McTiernan A. Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer 2012;20,267-277.
  • Naiman K, Dracinsky M, Hodek P, Martinkova M, Schmeiser HH, Frei E, Stiborova M. Formation, persistence, and identification of DNA adducts formed by the carcinogenic environmental pollutant o-anisidine in rats. Toxicol Sci 2012;127,348-359.
  • Rampoldi F, Sandhoff R, Owen RW, Grone HJ, Porubsky S. A new, robust, and nonradioactive approach for exploring N-myristoylation. J Lipid Res 2012;53,2459-2468.
  • Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M, Brenner H, Frank B, Bezieau S, Kury S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2012;131,217-234.
  • Nair J, Godschalk RW, Nair U, Owen RW, Hull WE, Bartsch H. Identification of 3,N(4)-Etheno-5-methyl-2'-deoxycytidine in Human DNA: A New Modified Nucleoside Which May Perturb Genome Methylation. Chem Res Toxicol 2012;25,162-169.
  • Marano G, Gronewold C, Frank M, Merling A, Kliem C, Sauer S, Wiessler M, Frei, E, Schwartz-Albiez R. An easily accessible sulfated saccharide mimetic inhibits in vitro human tumor cell adhesion and angiogenesis of vascular endothelial cells. Beilstein J Org Chem 2012;8,787-803.
    Haeck M, Franke S, Wiskemann J, Mathiak K. Psycho-oncology. Nervenarzt 2012;83,1468-1476.
  • Hutter CM, Chang-Claude J, Slattery ML, Pflugeisen BM, Lin Y, Duggan D, Nan H, Lemire M, Rangrej J, Figueiredo JC, Jiao S, Harrison TA, Liu Y, Chen LS, Stelling DL, Warnick GS, Hoffmeister M, Kury S, Fuchs CS, Giovannucci E, Hazra A, Kraft P, Hunter DJ, Gallinger S, Zanke BW, Brenner H, Frank B, Ma J, Ulrich CM, White E, Newcomb PA, Kooperberg C, LaCroix AZ, Prentice RL, Jackson RD, Schoen RE, Chanock SJ, Berndt SI, Hayes RB, Caan BJ, Potter JD, Hsu L, Bezieau S, Chan AT, Hudson TJ, Peters U. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 2012;72,2036-2044.
  • Degen C, Habermann N, Piegholdt S, Glei M, Jahreis G. Human colon cell culture models of different transformation stages to assess conjugated linoleic acid and conjugated linolenic acid metabolism: Challenges and chances. Toxicol In Vitro 2012;26,985-992.
  • Huebner J, Marienfeld S, Abbenhardt C, Ulrich CM, Loser C. How useful are diets against cancer? Dtsch Med Wochenschr 2012;137,2417-2422.
  • Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, McTiernan A, Bernstein L, Baumgartner KB, Ulrich CM, Ballard-Barbash R. Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol 2012;30,1280-1287.
  • Dee A, McKean-Cowdin R, Neuhouser ML, Ulrich CM, Baumgartner RN, McTiernan A, Baumgartner K, Alfano CM, Ballard-Barbash R, Bernstein L. DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a Cross-Sectional Analysis. BMC Cancer 2012;12,343.
  • Stiborova M, Levova K, Barta F, Shi Z, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Arlt VM. Bioactivation versus Detoxication of the Urothelial Carcinogen Aristolochic Acid I by Human Cytochrome P450 1A1 and 1A2. Toxicol Sci 2012;125,345-358.    
  • Vrieling A, Buck K, Heinz J, Obi N, Benner A, Flesch-Janys D, Chang-Claude J. Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res Treat 2012;136,195-207.
  • Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, Mahmoodi M, Schmidt MK, Broeks A, Cornelissen S, Braaf LM, Muir KR, Lophatananon A, Chaiwerawattana A, Wiangnon S, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, Sawyer EJ, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Guenel P, Truong T, Laurent-Puig P, Mulot C, Bojesen SE, Nielsen SF, Flyger H, Nordestgaard BG, Milne RL, Benitez J, Arias-Perez JI, Zamora MP, Anton-Culver H, Ziogas A, Bernstein L, Dur CC, Brenner H, Muller H, Arndt V, Langheinz A, Meindl A, Golatta M, Bartram CR, Schmutzler RK, Brauch H, Justenhoven C, Bruning T, Chang-Claude J, Wang-Gohrke S, Eilber U, Dork T, Schurmann P, Bremer M, Hillemanns P, Nevanlinna H, Muranen TA, Aittomaki, K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov Y, Bermisheva M, Prokofyeva D, Zinnatullina G, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Hartikainen JM, Kataja V, Chenevix-Trench, G, Beesley J, Chen X, Lambrechts D, Smeets A, Paridaens R, Weltens C, Flesch-Janys D, Buck K, Behrens S, Peterlongo P, Bernard L, Manoukian S, Radice P, Couch FJ, Vachon C, Wang X, Olson J, Giles G, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Mulligan AM, Weerasooriya N, Devilee P, Tollenaar RA, Martens JW, Seynaeve CM, Hooning MJ, Hollestelle A, Jager A, Tilanus-Linthorst MM, Hall P, Czene K, Liu J, Li J, Cox A, Cross SS, Brock IW, Reed MW, Pharoah P, Blows FM, Dunning AM, Ghoussaini M, Ashworth A, Swerdlow A, Jones M, Schoemaker M, Easton DF, Humphreys M, Wang Q, Peto J, Dos-Santos-Silva I. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2012;21,1783-1791.
  • Chen CY, Poole EM, Ulrich CM, Kulmacz RJ, Wang LH. Functional analysis of human thromboxane synthase polymorphic variants. Pharmacogenet Genomics 2012;22,653-658.    
  • Zaineddin AK, Buck K, Vrieling A, Heinz J, Flesch-Janys, D, Linseisen J, Chang-Claude J. The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study. Nutr Cancer 2012;64,652-665.
  • Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, Kaaks R, Chang-Claude J. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int J Cancer 2012;130,1401-1410.    
  • Berger N, Steindorf K, Ulrich CM. Introduction, In: Berger NA, Steindorf K, Ulrich CM. (Eds.). Exercise, Energy Balance and Cancer, Springer, New York 2012, pp. 1-5.
  • Steindorf K, Leitzmann M, Friedenreich CM. Physical activity and primary cancer prevention. In: Berger, N. A., Steindorf, K., Ulrich, C. M. (Eds.). Exercise, Energy Balance and Cancer, Springer, New York 2012, pp. 83-106
    Steindorf K, Schmidt M. Primärprävention. In: Baumann F, Bloch B, Jaeger E (Eds.). Sport und körperliche Aktivität in der Onkologie., Springer, Heidelberg 2012, pp. 43-54.
  • Steindorf K, Wiskemann J. Tertiärprävention. In: Baumann F, Bloch B, Jaeger E (Eds.). Sport und körperliche Aktivität in der Onkologie., Springer, Heidelberg 2012, pp. 55-68.
  • Wiskemann J, Hedrich C, Bannasch M. Krafttraining. In: Baumann F, Bloch B, Jaeger E (Eds.). Sport und körperliche Aktivität in der Onkologie., Springer, Heidelberg 2012, pp. 131-144.
  • Wiskemann J, Nies R, Vandenbergh D. Leukämien und Lymphome. In: Baumann F, Bloch B, Jaeger E (Eds.). Sport und körperliche Aktivität in der Onkologie., Springer, Heidelberg 2012, pp. 189-208.
  • Wiskemann J, Ulrich CM. Exercises during stem cell transplantation. In: Ulrich CM, Steindorf K, Berger NA. (Eds.), Exercise, Energy Balance and Cancer, Springer, New York 2012, pp. 143-158.
  • Ulrich CM, Steindorf K, Berger NA. Exercise, Energy Balance, and Cancer, Springer 2012.
  • De Roos AJ, Ulrich CM, Sjodin A, McTiernan A. Adiposity, body composition, and weight change in relation to organochlorine pollutant plasma concentrations. J Expo Sci Environ Epidemiol 2012;22,617-624.
  • Haass W, Stehle M, Nittka S, Giehl M, Schrotz-King P, Fabarius A, Hofmann WK, Seifarth W. The proteolytic activity of separase in BCR-ABL-positive cells is increased by imatinib. PLoS One 2012, 7, e42863.
  • Ramsey SD, Holmes RS, McDermott CL, Blough DK, Petrin KL, Poole EM, Ulrich CM. A comparison of approaches for association studies of polymorphisms and colorectal cancer risk. Colorectal Dis 2012, 14, e573-586.

  • Steindorf K, Schmidt M, Wiskemann J. Körperliche Aktivität nach der Krebsdiagnose - Erkenntnisse aus Langzeitbeobachtungen. Forum (Deutsche Krebsgesellschaft) 2011;26:38-41.
  • Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol 2011;35:345-352.    
  • Hadamofsky A, Eckert K, von Busch C, Huber G, Wiskemann J. Sport und Bewegung in der Pädiatrischen Onkologie - Entwicklung eines modularen Bewegungsprogramms am Zentrum für Kinder- und Jugendmedizin. Leipziger Sportwissenschaftliche Beiträge 2011;52:121-44.
  • Liedtke S, Schmidt ME, Becker S, Kaaks R, Zaineddin AK, Buck K, Flesch-Janys D, Wahrendorf J, Chang-Claude J, Steindorf K. Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI? Cancer Causes Control 2011;22:81-9.
  • Amann PM, Schadendorf D, Owen RW, Korn B, Eichmuller SB, Bazhin AV. Retinal and retinol are potential regulators of gene expression in the keratinocyte cell line HaCaT. Exp Dermatol 2011;20:373-5.
  • Arlt VM, Levova K, Barta F, Shi Z, Evans JD, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Stiborova M. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) mice. Chem Res Toxicol 2011;24:1710-9.
  • Ding R, Frei E, Fardanesh M, Schrenk HH, Kremer P, Haefeli WE. Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery. J Clin Pharmacol 2011;51:672-8.
  • Frei E. Albumin binding ligands and albumin conjugate uptake by cancer cells. Diabetol Metab Syndr 2011;3:11.
  • Funk D, Schrenk HH, Frei E. Development of a novel polyethylene glycol-corticosteroid-conjugate with an acid-cleavable linker. J Drug Target 2011;19:434-45.
  • Kotrbova V, Mrazova B, Moserova M, Martinek V, Hodek P, Hudecek J, Frei E, Stiborova M. Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy. Biochem Pharmacol 2011;82:669-80.
  • Levova K, Moserova M, Kotrbova V, Sulc M, Henderson CJ, Wolf CR, Phillips DH, Frei E, Schmeiser HH, Mares J, Arlt VM, Stiborova M. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model. Toxicol Sci 2011;121:43-56.
  • Martínek V, Kubickova B, Arlt VM, Frei E, Schmeiser HH, Hudecek J, Stiborova M. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases. Neuro Endocrinol Lett 2011, 32 Suppl 1, 57-70.
  • Mizerovska J, Dracinska H, Frei E, Schmeiser HH, Arlt VM, Stiborova M. Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats. Mutat Res 2011;720:34-41.
  • Naiman K, Martinkova M, Schmeiser* HH, Frei E, Stiborova M. Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity. Mutat Res 2011;726:160-8.
  • Stiborova M, Mareis J, Frei E, Arlt VM, Martinek V, Schmeiser HH. The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases. Environ Mol Mutagen 2011;52:448-59.
  • Stiborova M, Poljakova J, Martinkova E, Borek-Dohalska L, Eckschlager T, Kizek R, Frei E. Ellipticine cytotoxicity to cancer cell lines - a comparative study. Interdiscip Toxicol 2011;4:98-105.
  • Stiborova M, Rupertova M, Frei E. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency. Biochim Biophys Acta 2011;1814:175-85.  
  • Hodek P, Křížková J, Frei E, Singh R, Arlt VM, Stiborová M. Impact of beta-naphthoflavone on genotoxicity of food-derived carcinogens. Neuro Endocrinol Lett 2011;32 Suppl 1: 25-34.
  • Arlt VM, Singh R, Stiborova M, Gamboa da Costa G, Frei E, Evans JD, Farmer PB, Wolf CR, Henderson CJ, Phillips DH. Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct aormation in P450 reductase conditional null mice. Drug Metab Dispos 2011;39:2169-73.
  • Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, Seminara D, Goode EL, Yoo KY, Demers P, Gallagher R, Prentice R, Yasui Y, O'Doherty K, Petersen GM, Ulrich CM, Csizmadi I, Amankwah EK, Brockton NT, Kopciuk K, McGregor SE, Kelemen LE. Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer Causes Control 2011;22:463-8.
  • Slattery ML, Curtin K, Poole E, Duggan DJ, Wade SS, Peters U, Caan BJ, Potter JD, Ulrich CM, Genetic variation in C-reactive protein (CRP) in relation to colon and rectal cancer risk and survival. International Journal of Cancer 2011;128:2726-34.
  • Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut 2011;60:491-8.
  • Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Ulrich CM,  Bohus M. Effects of a partly self-administered exercise program before, during and after allogeneic stem cell transplantation. Blood 2011, 117:2604-13.
  • George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A, Alfano CM, Bernstein L, Ulrich CM, Baumgartner KB, Moore SC, Albanes D, Mayne ST, Gail MH, Ballard-Barbash R. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control; 2011; 22:589-98.
  • Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML. Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer 2011;63:357-66.
    Galbraith RL, Poole EM, Duggan D, Muehling J, Hsu L, Makar K, Xiao L, Potter JD, Ulrich CM. Polymorphisms in WNT6 and WNT10A and colorectal adenoma risk. Nutr Cancer 2011; 63:558-64.
  • Armbrecht A, Groschel A, Pottgen C, Reck M, Ruffer JU, Seifart U, Ulrich CM, Winter H. Nachsorge, Komplikationen und deren Therapie bei der operativen, strahlentherapeutischen und medikamentösen Therapie des Lungenkarzinoms. Onkologie 2011;34 Suppl 4:11-6.
  • Neuhouser M, Nijhout H, Gregory, JF III, Reed M, James SJ, Liu A, Shane B, Ulrich CM. Mathematical modeling predicts the effect of folate deficiency and excess on cancer- related biomarkers. Cancer Epidemiol Biomarkers Prev 2011;20:1912-1917.
  • Liu W, Poole EM, Ulrich CM, Kulmacz RJ. Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors. Pharmacogenomics J 2011;11:337-47.
  • Toriola AT, Ulrich CM. Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer? Future Oncol 2011;7:1125-8.
  • Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB. PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics 2011;21:679-86.
  • Reding KW, Lampe JW, Wang CY, Stanczyk FZ, Ulrich CM, Xiao L, Duggan CR, McTiernan A. A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations. Cancer Epidemiol 2011;35:569-573.
  • Villasenor A, Ambs A, Ballard-Barbash R, Baumgartner KB, McTiernan A, Ulrich CM, Neuhouser ML. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study. Breast Cancer Res Treat 2011;129:485-94.
  • Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain C, Campbell KL, Wang CY, Duggan CR, Ulrich CM, Alfano CM, Blackburn GL, McTiernan A. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med 2011;41:366-75.
  • Poole EM, Curtin K, Hsu L, Kulmacz RJ, Duggan DJ, Makar KW, Xiao L, Carlson CS, Slattery ML, Caan BJ, Potter JD, Ulrich CM. Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer. Int J Mol Epidemiol Genet 2011;2:300-15.
  • Coghill AE, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM. Genetic variation in inflammatory pathways is related to colorectal cancer survival. Clin Cancer Res 2011;17:7139-47.
  • Khallouki F, Haubner R, Ulrich CM, Owen RW. Ethnobotanical survey, chemical composition, and antioxidant capacity of methanolic extract of the root bark of annona cuneata oliv. J Med Food 2011;14:1397-402.
  • Williams L, Ulrich CM, Larson T, Wener MH, Wood B, Chen-Levy Z, Campbell PT, Potter J, McTiernan A, De Roos AJ. Fine particulate matter (PM(2.5)) air pollution and immune status among women in the Seattle area. Arch Environ Occup Health 2011;66:155-65.
  • Wiskemann J, Ulrich CM, Steindorf K. Effekte körperlichen Trainings auf die Psyche von Krebspatienten. Forum (Deutsche Krebsgesellschaft) 2011;26:42-8.

  • Becher H, Steindorf K. Epidemiologische Methoden und Wege der Risikoabschätzung. Informatik, Biometrie und Epidemiologie in Medizin und Biologie  1993;24:14-27.
  • Steindorf K, Schlehofer B, Becher H, Hornig G, Wahrendorf J. Nitrate in drinking water. A case-control study on primary brain tumors with an embedded drinking water survey in Germany. International Journal of Epidemiology 1994;23:451-457.
  • Steindorf K, Becher H. Estimation of unit risk and unit loss of lifetime in quantitative risk assessment. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 1994;25:225-232.
  • Lubin J, Steindorf K. Cigarette use and the estimation of lung cancer attributable to radon in the United States. Radiation Research 1995;141:79-85.
  • Steindorf K, Lubin J, Wichmann H-E, Becher H. Lung cancer deaths attributable to indoor radon exposure in West Germany. International Journal of Epidemiology, 1995;24:485-492.
  • Wichmann HE, Steindorf K, Becher H. Gehören strahlenepidemiologische Modelle neuerdings in den Papierkorb? Bundesgesundheitsblatt 1996;39:393-395.
  • Becher H, Flesch-Janys D, Kauppinen T, Kogevinas M, Steindorf K, Manz A, Wahrendorf J. Cancer mortality in German male workers exposed to phenoxy herbicides and dioxins. Cancer Causes and Control  1996;7:312-321.
  • Popiela T, Jedrychowski W, Steindorf K, Matyja A, Gryglewski A, Nowak K, Kieltyka A, Wahrendorf J, Becher H. Controlled clinical studies for topographic analysis of atrophic gastritis and stomach cancer (in Polish). Przeglad Lekarski 1996;53:472-477.
  • Ulrich CM, Georgiou CC, Snow-Harter CM, Gillis, D.  Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements.  American Journal of Clinical Nutrition 1996;63:72-9.
  • Jedrychowski W, Popiela T, Steindorf K, Matyja A, Gryglewski A, Nowak K, Kieltyka A, Wahrendorf J, Becher H.  A topographic analysis of atrophic gastritis and stomach cancer risk. A clinicoepidemiological study in Poland. Central European Journal of Public Health 1997;3:117-121.
  • Becher H, Steindorf K, Flesch-Janys D.  Quantitative cancer risk assessment for dioxins using an occupational cohort. Environmental Health Perspectives 1998;106:663 - 670.
  • Flesch-Janys D, Becher H, Berger J, Dwyer JH, Gurn P, Nagel S, Steindorf K, Waltsgott H. (1998): Aspekte zu Dosis-Wirkungsbeziehungen bezüglich der Mortalität an bösartigen Neubildungen und kardiovaskulären Erkrankungen und der Exposition gegenüber polychlorierten Dibenzo-Dioxinen und -Furanen (PCDD/F) in einer beruflich belasteten Kohorte. Arbeitsmedizin Sozialmedizin Umweltmedizin 1998,24:54-59.
  • Flesch-Janys D, Steindorf K, Gurn P, Manz A, Becher H. Estimation of the cumulated exposure to polychlorinated dibenzo-p-dioxins/furans and SMR analysis of cancer mortality by dose in an occupationally exposed cohort. Environmental Health Perspectives 1998;106:655-662.
  • Steindorf K, Becher H. Absolute risk and loss-of lifetime estimates for quantitative risk assessment. Biometrical Journal 1998;40:355-378.
  • McTiernan A, Ulrich CM, Kumai C, Bean D, Schwartz R, Mahloch J, Hastings R, Gralow J, Potter JD.  Anthropometric and Hormone Effects of an 8-Week Exercise-Diet Intervention in Breast Cancer Patients: Results of a Pilot Study. Cancer Epidemiology, Biomarkers and Prevention 1998;7:477-481.
  • Röttger-Liepmann B, Ulrich CM, Laaser U.  Telefonische Befragung zu genetischen Tests für Brust- und Prostatakrebsrisiko. Fortschritte der Medizin, 1998; 116 (Suppl 3):95-99.
  • Röttger-Liepmann B, Ulrich CM, Laaser U.  Akzeptanz genetischer Tests in der Bevölkerung. Fortschritte der Medizin, 1998; 116(27):43.
  • McTiernan A, Ulrich C, Slate S, Potter JD.  Physical activity and cancer etiology: associations and mechanisms (review). Cancer Causes and Control, 1998;9:487-509.
  • Ulrich CM, Kristal AR, White E, Durfy SJ, Hunt JR, Potter JD. Genetic testing for cancer risk: A population survey on attitudes and intention. Community Genetics 1998;1:213-222.
  • Tatsis E, Reinhold-Keller E, Steindorf K, Feller A, Gross, W.  Wegener’s granulomatosis is associated with malignancy. Arthritis & Rheumatism 1999;42:751-756.
  • Flesch-Janys D, Becher H, Berger J, Manz A, Morgenstern I, Nagel S, Steindorf K.  Epidemiologic investigation of breast cancer incidence in a cohort of female workers with high exposure to polychlorinated dibenzo-p-dioxins and hexachlorcyclohexane. Organohalogen compounds 1999;44:379-382.
  • Ulrich CM, Georgiou CC, Gillis DE, Snow CM. Lifetime physical activity is associated with bone mineral density in premenopausal women. Journal of Women’s Health 1999;8(3):365-375.
  • Ulrich CM, Kampman E, Bigler J, Schwartz S, Chen C, Bostick R, Fosdick L, Beresford SAA, Yasui Y, Potter JD. Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction? Cancer Epidemiology Biomarkers and Prevention 1999; 8(8):659-668.
  • McTiernan A, Ulrich CM, Yancey D, Slate S, Bowen D, Nakamura H, Schwartz R, Potter JD. The PATH Study: Rationale and study design. Medicine and Science in Sports and Exercise 1999;31(9):1307-1312.
  • Ulrich CM, Kampman E, Bigler J, Schwartz S, Chen C, Bostick R, Fosdick L, Beresford SAA, Yasui Y, Potter JD.  Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiology Biomarkers and Prevention 2000;9:427-433.
  • Steindorf K, Tobiasz-Adamczyk B, Popiela T, Jedrychowski W, Penar A, Matyja A, Wahrendorf J. Combined risk assessment of physical activity and dietary habits on the development of colorectal cancer. A hospital-based case-control study in Poland. European Journal of Cancer Prevention 2000;9:309-316.
  • Becher H, Grau A, Steindorf K, Buggle F, Hacke W. Previous infection and other risk factors for acute cerebrovascular ischemia: Attributable risks and the characterisation of high risk groups. Journal of Epidemiology and Biostatistics 2000; 5: 277-283.
  • Grembowski DE, Diehr P, Novak LC, Roussel AE, Martin DP, Patrick DL, Williams B, Ulrich CM. Measuring the “managedness” and covered benefits of health plans. Health Services Research 2000;35(3):707-34.
  • Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin F, Potter JD. Searching expressed sequence tag (EST) databases: Discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiology, Biomarkers and Prevention 2000;12:1381-1385.
  • Jedrychowski W, Steindorf K, Popiela T, Wahrendorf J, Tobiasz-Adamczyk B, Kulig J, Penar A. Risk of colorectal cancer from alcohol consumption at lower vitamin intakes. A hospital-based case-control study in Poland. Reviews on Environmental Health 2001;16:213-222.
  • Jedrychowski W, Popiela T, Steindorf K, Tobiasz-Adamczyk B, Kulig J, Penar A, Wahrendorf J. Nutrient intake patterns in gastric and colorectal cancers. International Journal of Occupational Medicine and Environmental Health 2001;14:391-395.
  • Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD. Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the 5,10-methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001;98:231-4.
  • Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiology, Biomarkers and Prevention 2001;10:875-82.
  • Kim HS , Newcomb PA, Ulrich CM, Keener CL, Farin FM, Bostick RM, Potter JD Vitamin D receptor polymorphisms and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiology, Biomarkers and Prevention 2001;10:869-74.
  • Jedrychowski W, Tobiasz-Adamczyk B, Steindorf K, Popiela T, Penar A, Matyja A, Wahrendorf J. Protective effects of physical activity in the occurrence of colon cancer (in Polish). Przeglad Lekarski 2002;59:21-25.
  • Jedrychowski W, Steindorf K, Popiela T, Wahrendorf J, Tobiasz-Adamczyk B, Kulig J, Penar A. Alcohol consumption and the risk of colorectal cancer at low levels of micronutrient intake. Medical Science Monitor 2002;8:357-363.
  • Tworoger SS, Yasui Y, Ulrich CM, Nakamura H, LaCroix K, Johnston R, McTiernan A. Mailing strategies and recruitment into an intervention trial of the exercise effect on breast cancer biomarkers. Cancer Epidemiology Biomarkers Prevention 2002;11:73-7.
  • Ulrich CM, Robien K, Sparks R. Pharmacogenetics and folate metabolism – a promising direction (invited review). Pharmacogenomics 2002;3:299-313.
  • Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD. Thymidylate Synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenoma. Cancer Research 2002;62:3361-4.
  • Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CL, Potter JD. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiology, Biomarkers and Prevention 2002;11:1012-8.
  • Ulrich CM, Bigler J, Sibert J, Greene EA, Sparks R, Carlson CS, Potter JD. Cyclooxygenase 1 (COX-1) polymorphisms in African-American and Caucasian populations. Human Mutation 2002;20:409-10.
  • Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk (review). Cancer Epidemiology, Biomarkers and Prevention 2002;11:1513-30.
  • Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: A randomized controlled trial. JAMA 2003;289:323-30.
  • Robien K, Ulrich CM. 5,10-methylenetetrahydrofolate reductase polymorphisms and leukemia risk: A HuGE minireview. American Journal of Epidemiology 2003;157:571-82.
  • Steindorf K, Schmidt M, Kropp S, Chang-Claude J. Case-control study of physical activity and breast cancer risk among premenopausal women in Germany. American Journal of Epidemiology 2003;157:121-130.
  • Adzersen K, Becker N, Steindorf K, Frentzel-Beyme R. Cancer mortality in a cohort of male german iron foundry workers. American Journal of Industrial Medicine 2003; 43: 295-305.
  • Mitchell BL, Ulrich CM, McTiernan A. Supplementation with vitamins or minerals and immune function: Can the elderly benefit? Nutrition Research 2003;23:1117-39.
  • Grembowski D, Ulrich CM, Paschane D, Diehr P, Katon W, Martin D, Patrick DL, Velicer C. Managed care and primary physician satisfaction. Journal of the American Board of Family Practice 2003;16:383-93.
  • Chang CK, Ulrich CM. Hyperinsulinemia and hyperglycemia: Possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003;46:595-609.
  • Tworoger SS, Yasui Y, Vitiello M, Schwartz RS, Ulrich CM, Aiello EJ, Irwin ML, Bowen D, Potter JD, McTiernan A. Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep 2003;26:830-6.
  • Ulrich CM, Robien K, McLeod H. Cancer pharmacogenetics: Polymorphisms, pathways, and beyond. Nature Reviews Cancer 2003;12:912-20.
  • Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe J, Farin FM, Stanczyk FZ, McTiernan A. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2004;13:94-101.
  • Shade ED, McTiernan A, Wener MH, Wood B, Yasui Y, LaCroix K, Potter JD, Ulrich CM. Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity constituting possible long-term effects on immune function. Journal of the American Dietetic Association 2004;104:903-12.
  • Reed MC, Nijhout HF, Sparks R, Ulrich CM. A mathematical model of the methionine cycle. Journal of Theoretical Biology 2004;226:33-43.
  • Goode EL, Potter JD, Bigler J, Ulrich CM. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiology, Biomarkers, and Prevention 2004;13:157-62.
  • Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms – diet, estrogen, and risk of colon cancer.  Cancer Epidemiology, Biomarkers and Prevention 2004;13:285-92.
  • Sparks R, Bigler J, Sibert JG, Potter JD, Yasui Y, Ulrich CM. TGFb1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps. International Journal of Epidemiology 2004;33:1-7.
  • Ulrich CM, Bigler J, Sparks R, Whitton J, Sibert JG, Goode EL, Yasui Y, Potter JD. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps. Cancer Epidemiology, Biomarkers and Prevention 2004;13:889-93.
  • Robien K, Schubert MM, Lloid ME, Bruemmer B, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. Journal of Clinical Oncology 2004;22:1268-75.
  • McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan B, Rudolph RE, Bowen D, Stanczyk F, Potter JD, Schwartz RS. Effect of exercise on serum estrogen in postmenopausal women: a 12-month randomized clinical trial. Cancer Research 2004; 64:2923-28.
  • Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, Schwartz RS, Kumai C, Potter JD, McTiernan A. Effect of a yearlong moderate-intensity exercise intervention on the occurrence and severity of menopausal symptoms in postmenopausal women. Menopause 2004;4:382-8.
  • Atkinson C, Lampe JW, Tworoger SS, Ulrich CM, Bowen D, Irwin ML, Schwartz RS, Rajan BK, Yasui Y, Potter JD, McTiernan A. Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2004;13:868-74.
  • Hazelton WD, Tien JH, Donato VW, Sparks R, Ulrich CM. Prostaglandin H synthases: members of a class of quasi-linear threshold switches. Biochemical Pharmacology 2004;68:423-32.
  • Tworoger SS, Chubak J, Aiello EJ, Yasui Y, Ulrich CM, Farin FM, Stapleton PL, Irwin ML, Potter JD, Schwartz RS, McTiernan A. The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obesity Research 2004;12:972-80.
  • Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, Lin MG, McVarish L, Aiello E, McTiernan A. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex-hormone concentrations, and tumor characteristics in breast cancer patients. Breast Cancer Research 2004;6:R488-98.
  • McTiernan A, Tworoger SS, Rajan B, Yasui Y, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Sorensen B, Rudolph RE, Potter JD, Schwartz RS. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiology, Biomarkers and Prevention 2004;13:1099-1105.
  • Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiology, Biomarkers and Prevention 2004;13:1296-1301.
  • Irwin ML, Tworoger SS, Yasui Y, Rajan B, McVarish L, LaCroix K, Ulrich CM, Bowen D, Schwartz RS, Potter JD, McTiernan A. Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Preventive Medicine 2004;39:1080-6.
  • Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radich JR. Methylenetetrahydrofolate reductase genotype affects risk of relapse following hematopoietic cell transplantation for chronic myelogenous leukemia. Clinical Cancer Research 2004;10:7592-8.
  • Nijhout HF, Reed MC, Budu P, Ulrich CM. A mathematical model of the folate cycle – new insights into folate homeostasis. Journal of Biological Chemistry 2004;279:55008-16.
  • Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Molecular Carcinogenesis 2005;42:127-41.
  • Steindorf K, Jedrychowski W, Schmidt M, Popiela T, Penar A, Galas A, Wahrendorf J. Case-control study of lifetime occupational and recreational physical activity and risks of colon and rectal cancer. European Journal of Cancer Prevention 2005;14,363-371.
  • Chang-Claude J, Hermann S, Eilber U, Steindorf  K. Life-style determinants and mortality in German vegetarians and health-conscious persons: Results of 21 years follow-up. Cancer Epidemiology, Biomarkers, and Prevention 2005;14,963-968.
  • Ulrich CM, Whitton J, Yu J-H, Sibert J, Sparks R, Potter JD, Bigler J. PTGS2 (COX-2) –765G>C promoter variant reduces risk of colorectal adenoma among non-users of NSAIDs. Cancer Epidemiology, Biomarkers and Prevention 2005;14:616-9.
  • Tien JH, Hazelton WD, Sparks R, Ulrich CM. A Michaelis-Menten-style model for the autocatalytic enzyme Prostaglandin H Synthase. Bulletin of Mathematical Biology 2005; 67:683-700.
  • McTiernan A, Sorensen BE, Yasui Y, Tworoger ST, Ulrich CM, Irwin ML, Rebecca RE, Stanczyk FZ, Schwartz RS, Potter JD. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding-protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiology, Biomarkers and Prevention 2005;14:1020-1.
  • Frank LL, Sorensen BE, Yasui Y, Tworoger ST, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan B, Stanczyk F, Bowen D, Weigle DS, Potter JD, McTiernan A. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obesity Research 2005;13:615-25.
  • Robien K, Curtin K, Ulrich CM, Bigler J, Samowitz W, Caan B, Potter JD, Slattery ML. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiology, Biomarkers, and Prevention 2005;14:1350-2.
  • Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter JD, Ulrich CM, Irwin M, McTiernan A. Associations among circulating sex hormones, insulin-like growth factors, lipids, and mammographic density in postmenopausal women. Cancer Epidemiology, Biomarkers, and Prevention 2005;14:1411-7.
  • Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations. Journal of Women’s Health 2005:14;704-12.
  • Ulrich CM, Carlson CS, Sibert J, Poole EM, Yu JH, Wang LH, Sparks R, Potter JD, Bigler J. Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations – evidence for selective pressure? Human Mutation 2005;26:394-5.
  • Ulrich CM. Nutrigenetics in cancer research – folate metabolism and colorectal cancer. Journal of Nutrition 2005;135:2689-702.
  • Ulrich CM, Curtin K, Samowitz W, Bigler J, Potter JD, Caan B, Slattery ML. MTHFR variants reduce the risk of G:C>A:T transition mutations within the p53 tumor suppressor gene in colon tumors. Journal of Nutrition 2005;135:2462-7.
  • Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase, and risk of colon cancer. Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2509-16. These authors contributed equally.
  • Meyers JA, McTiernan A, Ulrich CM. Leptin and immune function – integrating the evidence. Nutrition Research 2005;9:791-803.
  • Bigler J, Ulrich CM, Kawashima T, Whitton J, Potter JD. DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps. Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2501-8.
  • Robien K, Boynton A, Ulrich CM. Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005;6:673-89.
  • Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2524-30.
  • Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Potter JD, Ulrich CM. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. Journal of Nutrition 2006;136:189-94.
  • Ulrich CM, Potter JD. Folate supplementation – too much of a good thing? (editorial). Cancer Epidemiology, Biomarkers, and Prevention 2006;15:189-93.
  • Mohanka M, Irwin M, Heckbert SR, Yasui Y, Sorensen B, Chubak J, Tworoger SS, Ulrich CM, McTiernan A. Serum lipoproteins in overweight/obese postmenopausal women: a one year exercise trial. Medicine Science, Sports & Exercise 2006;38:231-9.
  • Robien K, Schubert MM, Yasui Y, Martin P, Storb R, Potter JD, Ulrich CM. Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-vs-host disease or relapse following hematopoietic transplantation. Bone Marrow Transplantation 2006;37:687-92.
  • Poole EM, Bigler J, Whitton J, Potter JD, Sibert JG, Ulrich CM.  Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.  Cancer Epidemiology, Biomarkers, and Prevention 2006;15:502-8.
  • Robien K, Schubert MM, Chay T, Bigler J, Storb R, Yasui Y, Potter JD, Ulrich CM. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation (letter). Bone Marrow Transplantation 2006;37:799-800.
  • Nijhout HF, Reed M, Anderson D, Mattingly J, James SJ, Ulrich CM. Long-range allosteric interactions between the folate and methionine cycles stabilize DNA methylation reaction rate. Epigenetics 2006;1:81-7.
  • Yu JH, Bigler J, Whitton J, Potter JD, Ulrich CM. Mismatch repair polymorphisms and colorectal polyps: hMLH1 -93G>A variant modifies risk associated with smoking. American Journal of Gastroenterology 2006;101:1313-9.
  • Schmidt ME, Steindorf K. Statistical methods for the validation of questionnaires: discrepancies between theory and practice. Methods of Information in Medicine 2006; 45: 409-413.
  • Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR. Lack of association of herpesviruses with brain tumors. Journal of NeuroVirology 2006; 12: 90-99.
  • Jedrychowski W, Galas A, Pac A, Schmidt M, Popiela T, Wahrendorf J, Steindorf K. Physical activity over lifetime and the occurrence of stomach cancer: case-control study in Poland. Polski Przeglad chirurgiczny 2006; 78: 424-437.
  • Friedenreich C, Norat T, Steindorf K, Boutron-Ruault MC, Pischon T, Mazuir M, Clavel-Chapelon F, Linseisen J, Boeing H, Bergman M, Johnsen NF, Tjonneland A, Overvad K, Mendez M, Quiros JR, Martinez C, Dorronsoro M, Navarro C, Gurrea AB, Bingham S, Khaw KT, Allen N, Key T, Trichopoulou A, Trichopoulos D, Orfanou N, Krogh V, Palli D, Tumino R, Panico S, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Monninkhof E, Berglund G, Manjer J, Ferrari P, Slimani N, Kaaks R, Riboli E. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiology, Biomarkers, and Prevention 2006; 15: 2398-2407.
  • Schmidt M, Slanger T, Chang-Claude J, Wahrendorf J, Steindorf K. Relative evaluation of a short retrospective questionnaire for physical activity in women. European Journal of Epidemiolog 2006; 21: 575-585.
  • Steindorf K, Friedenreich C, Linseisen J, Rohrmann S, Rundle A, Veglia F, Vineis P, Fønns Johnsen N, Tjønneland A, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Boutron-Ruault M-C, Schulz M, Boeing H, Trichopoulou A, Kalapothaki V, Koliva M, Krogh V, Palli D, Tumino R, Panico S, Monninkhof E, Peeters PH, Boshuizen HC, Bueno-de-Mesquita HB, Chirlaque M-D, Agudo A, Larrañaga N, Quirós JR, Martínez C, Barricarte A, Janzon L, Berglund G, Bingham S, Khaw KT, Key TJ, Norat T, Jenab M, Cust A, Riboli E. Physical activity and lung cancer risk in the European Investigation into Cancer and Nutrition (EPIC) cohort. International Journal of Cancer 2006; 119: 2389-2397.
  • Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, Stanczyk FZ, Potter JD, McTiernan A. Effect of exercise on bone mineral density, and lean mass in postmenopausal women. Medicine and Science in Sports and Exercise 2006;38:1236-44.
  • Ambrosone CB, Rebbeck TR, Morgan GJ, Albain KS, Calle EE, Evans WE, Hayes DF, Kushi LH, McLeod HL, Rowland JH, Ulrich CM. New developments in the epidemiology of cancer prognosis: Traditional and molecular predictors of treatment response and survival. Cancer Epidemiology, Biomarkers, and Prevention 2006;15:2042-6.
  • Ulrich CM, Nijhout HF, Reed MC. Mathematical modeling: epidemiology meets systems biology (editorial). Cancer Epidemiology, Biomarkers, and Prevention 2006;15:827-9.
  • Potter JD, Ulrich CM. COX-2 and gastric cancer: more on inflammation and neoplasia (editorial). Gastroenterology 2006;130:2198-2200.
  • Chang JL, Chen G, Lampe JW, Ulrich CM. DNA damage and repair measurements from cryopreserved lymphocytes without cell culture – a reproducible assay for intervention assays. Environmental and Molecular Mutagenesis 2006;47:503-8.
  • Ulrich CM, Bigler J, Potter JD. Genetic tools to tailor cancer prevention by NSAIDs. Discovery Medicine 2006;6:71-4.
  • Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Chen C. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecologic Oncology 2006;103:891-6.
  • Robien K, Bigler J, Yasui Y, Potter JD, Martin P, Storb R, Ulrich CM. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-vs-host disease following hematopoietic cell transplant for chronic myelogenous leukemia. Biology of Blood and Marrow Transplantation 2006;12:973-80.
  • Reed MC, Nijhout HF, Neuhouser ML, Gregory JF IIIrd, Shane B, James SJ, Boynton A, Ulrich CM. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. Journal of Nutrition 2006;136:2653-2661.
  • Chubak J, McTiernan A, Sorensen B, Wener MH, Yasui Y, Velasquez M, Wood B, Rajan KB, Wetmore CM, Potter JD, Ulrich CM. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. American Journal of Medicine 2006;119:937-42.
  • Bowen DJ, Fesinmeyer MD, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Rudolph RE, LaCroix KL, Schwartz RR, McTiernan A. Effects of physical activity on quality of life in sedentary middle aged women. International Journal of Behavioral Nutrition and Physical Activity 2006;3:34.
  • Nijhout HF, Reed MC, Lam SL, Shane B, Gregory JF, Ulrich CM. In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theoretical Biology and Medical Modeling 2006;3:40 doi:10.1186/1742-4682-3-40.
  • Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nature Reviews Cancer 2006;6:130-140, reprinted in Nature Reviews Cancer, Biomarkers Collection, 2007:S23-33.
  • Littman AJ, Vittielo MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, Weigle DS, McTiernan A. Sleep, ghrelin, leptin, and changes in body weight during a 1-year moderate-intensity physical activity intervention. International Journal of Obesity 2007;31:466-75.
  • Bigler J, Sibert JG, Poole EM, Carlson CS, Potter JD, Ulrich CM. Polymorphisms predicted to alter function in prostaglandin E2 synthase and prostaglandin E2 receptors. Pharmacogenetics 2007;17:221-7.
    Grady WM, Ulrich CM. DNA alkylation and DNA methylation: cooperating mechanisms driving colorectal carcinogenesis. (commentary) Gut 2007;56:318-20.
  • Friedenreich C, Cust A, Lahmann PH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S, Linseisen J, Rohrmann S, Boeing H, Pischon T, Tjonneland A, Halkjaer J, Overvad K, Mendez M, Redondo ML, Garcia CM, Larranaga N, Tormo MJ, Gurrea AB, Bingham S, Khaw KT, Allen N, Key T, Trichopoulou A, Vasilopoulou E, Trichopoulos D, Pala V, Palli D, Tumino R, Mattiello A, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Berglund G, Manjer J, Lundin E, Lukanova A, Slimani N, Jenab M, Kaaks R, Riboli E.  Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes and Control 2007;18:399-413.
  • Friedenreich C, Cust A, Lahmann PH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S, Linseisen J, Rohrmann S, Pischon T, Schulz M, Tjonneland A, Johnsen NF, Overvad K, Mendez M, Arguelles MV, Garcia CM, Larranaga N, Chirlaque MD, Ardanaz E, Bingham S, Khaw KT, Allen N, Key T, Trichopoulou A, Pala V, Palli D, Tumino R, Panico S, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Monninkhof E, Berglund G, Manjer J, Slimani N, Ferrari P, Kaaks R, Riboli E. Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. International Journal of Cancer 2007;121:347-55.
  • Veglia F, Vineis P, Overvad K, Boeing H, Bergmann M, Trichopoulou A, Trichopoulos D, Palli D, Krogh V, Tumino R, Linseisen J, Steindorf K, Raaschou-Nielsen O, Tjonneland A, Gonzalez C, Martinez C, Dorronsoro M, Barricarte A, Cirera L, Quiros J, Day NE, Saracci R, Riboli E. Occupational exposures, environmental tobacco smoke and lung cancer in the EPIC prospective study. Epidemiology 2007;18:769-775.
  • Steindorf K: Körperliche Aktivität und Krebsprävention. The Medical Journal, Schweizer Zeitschrift für Innere Medizin, 2007;15,35-37.
  • Abrahamson PE, Tworoger SS, Aiello EJ, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Bernstein L, Sorensen B, Ballard-Barbash R, McTiernan A. Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in postmenopausal breast cancer survivors. Breast Cancer Research and Treatment 2007; 105: 45-54.
  • Curtin K, Ulrich CM, Bigler J, Samowitz WS, Caan B, Potter JD, Slattery ML. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics, and survival. Int J Cancer 2007;120:2226-32.
  • Tworoger SS, Sorensen B, Chubak J, Irwin M, Stanczyk FZ, Ulrich CM, Potter JD, McTiernan A. Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2007;16:895-99.
  • Poole EM, Bigler J, Whitton J, Sibert JG, Kulmacz RJ, Potter JD, Ulrich CM. Genetic variability in prostaglandin synthesis, fish intake, and risk of colorectal polyps. Carcinogenesis 2007;28:1259-63.
  • Ulrich CM, Potter JD. Folate and cancer – timing is everything (editorial). JAMA 2007;297:2408-9.
  • Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 2007; 28(8): 1672-79.
  • Ulrich CM. Folate and cancer prevention – a closer look at a complex picture (editorial). Am J Clin Nutr 2007;86:271-273.
  • Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser M, Potter JD, Tworoger SS, Chubak, Bowen DJ, McTiernan A. Minimal effects of an exercise intervention trial on self-reported health behaviors in obese post-menopausal women. Contemporary Clinical Trials 2007; 28: 472-81.
  • Campbell KL, McTiernan A, Li SS, Sorensen BE, Yasui Y, Lampe JW, King IB, Ulrich CM, Rudolph RE, Irwin ML, Surawicz C, Ayub K, Potter JD, Lampe PD. Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial. Cancer Epidemiology, Biomarkers, and Prevention 2007;16:1767-74.
  • Boynton AM, Neuhouser ML, Wener MH, Wood B, Sorensen B, Chen-Levy Z, Kirk EA, Yasui Y, LaCroix K, McTiernan A, Ulrich CM. Associations between healthy eating patterns and immune function in postmenopausal women. American Journal of Clinical Nutrition 2007;86:1445-55.
  • Abrahamson PE, King I, Sorensen B, Potter JD, Lampe J, Yasui Y, Ulrich CM, McTiernan A. No effect of exercise on colon mucosal prostaglandin concentrations: A 12-month randomized controlled trial. Cancer Epi Biomarkers Prev 2007;16:2351-6.
  • Nijhout HF, Reed MC, Ulrich CM.  A day in the life of cell metabolism. Biological Theory 2007;2:124-7.
  • Boynton AM, Neuhouser ML, Sorensen B, McTiernan A, Ulrich CM. Predictors of diet quality among overweight or obese postmenopausal women. Journal of the American Dietetic Association 2008;108:125-30.
  • Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. Journal of Clinical Oncology 2008;26:665-73.
  • Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiology, Biomarkers and Prevention 2008;17:330-8.
  • Schmidt ME*, Steindorf K*, Mutschelknauss E, Slanger T, Obi N, Kropp S, Flesch-Janys D, Chang-Claude J. Physical activity and postmenopausal breast cancer: effective periods in life and effect modification by different breast cancer characteristics. Cancer Epidemiology Biomarkers and Prevention 2008;17:3402–10. (* Shared first-authorship)
  • Steindorf K Multifactorial prevention, risk of cancer and physical activity. Onkologie 2008; 31:10-11.
  • Hoffmann W, Latza U, Terschüren C, Berger K, Bergmann M, Dahl A, Fendrich K, Gierer S, Holle R, Jahn I, Schümann M, Steindorf  K. Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP, 2. Aufl.. Erste Aufl.: Kurth BM, Hense HW, Hoffmann W, Ahrens W, Babitsch B, Becher H, Blettner M, Brasche S, Brenner H, Enderlein G, Greiser KH, Jahn I, Jöckel KH, KirschnerW, Kohlmann T, Liese A, Möhner M, Mueller U, Reintjes R, Stang A,Wyst M.) 2008;http://www.dgepi.de/pdf/infoboard/stellungnahme/GEP.
    Barnes BE, Chang-Claude J, Flesch-Janys D, Kinscherf R, Schmidt M, Slanger T, Bonaterra G, Steindorf K.  Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status. Cancer Causes Control 2008; 20: 1985-1996.
  • Hawkins V, Foster-Schubert KE, Chubak J, Sorensen B, Ulrich CM, Stanczyk FZ, Plymate S, Stanford JL, White E, Potter JD, McTiernan A. Effect of exercise on serum sex hormones in men: A 12-month randomized controlled clinical trial. Medicine and Science in Sports and Exercise 2008;40:223-33.
  • Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF. A mathematical model of glutathione metabolism. Theoretical Biology & Medical Modelling 2008;5:8. doi: 10.1186/1742-4682-5-8.
    Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008;229:2423-36.
  • Ulrich CM, Holmes RS. Shedding light on colorectal cancer prognosis – vitamin D and beyond. Journal of Clinical Oncology 2008;26:2937-9.
  • Campbell PT, Wener MH, Sorensen B, Wood B, Potter JD, McTiernan A, Ulrich CM. Effect of exercise on immune function: a 12-month randomized controlled trial among postmenopausal women. Journal of Applied Physiology 2008;104:1648-55.
  • Luebeck EG, Moolgavkar SH, Boynton A, Liu AY, Ulrich CM. Does folic-acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiology, Biomarkers, and Prevention 2008;17:1360-7.
  • Campbell KL, Campbell PT, Ulrich CM, Wener MW, Alfano CM, Foster-Schubert KE, Rudolph RE, Potter JD, McTiernan A. No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epidemiology, Biomarkers and Prevention 2008;17:1714-8.
  • Cross JT, Poole EM, Ulrich CM. A review of gene-drug interactions for non-steroidal anti-inflammatory drug (NSAID) use in preventing colorectal neoplasia. The Pharmacogenomics Journal 2008;8:237-47.
  • Wayne SJ, Neuhouser ML, Ulrich CM, Koprowski C, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash. Dietary fiber is associated with serum sex hormones, insulin-related peptides, and leptin in postmenopausal breast cancer survivors. Breast Cancer Research & Treatment 2008;112:149-58.
  • Ulrich CM, Reed MC, Nijhout HF. Modeling folate, one-carbon metabolism, and DNA methylation. Nutrition Reviews 2008;66:S27-30.
  • Ulrich CM. Folate and cancer prevention: where to next? (editorial) Cancer Epidemiology, Biomarkers and Prevention 2008;17:2226-30.
  • Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JG 3rd, Shane BS, James SJ, Reed MC, Nijhout HF.  Mathematical modeling of folate metabolism: Predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiology, Biomarkers, and Prevention 2008;17:1822-31.
  • Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R.  Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. American Journal of Clinical Nutrition 2008;88:133-9.
  • Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, Caan BJ, Ulrich CM, Potter JD, Slattery ML. The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes, Chromosomes, and Cancer 2008;47:835-44.
  • Dong L, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Caan BJ, Potter JD, Peters U. Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiology, Biomarkers, and Prevention 2008;17:2755-65.
  • Meyers JA, McTiernan A, Wener MH, Wood B, Weigle DS, Sorensen B, Chen-Levy Z, Yasui Y, Boynton A, LaCroix K, Potter JD, Ulrich CM. Serum leptin concentrations and markers of immune function in overweight and obese postmenopausal women. Journal of Endocrinology 2008;199:51-60.
  • Wayne S, Neuhouser ML, Ulrich CM, Koprowski C, Wiggins C, Baumgartner KB, Bernstein L, Baumgartner RN, Gilliland F, McTiernan A, Ballard-Barbash R.  The association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors. Cancer Epidemiology, Biomarkers and Prevention 2008;17:3224-32.
  • Campbell KL, Makar KW, Kratz M, Foster-Schubert KE, McTiernan A, Ulrich CM. A pilot study of sampling subcutaneous adipose tissue to examine biomarkers of cancer risk. Cancer Prevention Research 2009;2:37-42.
  • Poole EM, Bigler J, Whitton J, Sibert JG, Carlson CS, Potter JD, Ulrich CM.  C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenetics and Genomics 2009;19:113-20.
  • Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Mutschelknauss E, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a case-control-study. Cancer Epidemiology, Biomarker, and Prevention 2009; 18: 2207-2213.
  • Schmidt ME, Chang Claude J, Slanger T, Obi N, Flesch Janys D, Steindorf K. Physical activity and postmenopausal breast cancer: effect modification by other breast cancer risk factors. Methods of Information in Medicine 2009; 48: 444-450.
  • Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R. Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users. Breast Cancer Research and Treatment 2009;117:111-9.
  • Williams L, Ulrich CM, Larson T, Wener MH, Wood B, Potter JD, McTiernan A, DeRoos AJ. Proximity to traffic, inflammation and immune function among women in the Seattle, Washington, area. Environmental Health Perspectives 2009;117:373-378.
  • Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, Ulrich CM. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Research and Treatment 2009;114:155-67.
  • Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML. Mismatch repair polymorphisms and risk of colon cancer, tumor microsatellite instability, and interactions with lifestyle factors. Gut 2009 May;58(5):661-7.
  • Maruti SS, Ulrich CM, White E.  Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. American Journal of Clinical Nutrition 2009;89:624-33.
  • Campbell PT, Campbell KL, Wener MH, Wood BL, Potter JD, McTiernan A, Ulrich CM. A yearlong exercise intervention decreases CRP among obese postmenopausal women. Medicine and Science in Sports and Exercise 2009;41(8):1533-39.
  • Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology 2009: 27:3437-44.
  • Nijhout HF, Gregory JF, Fitzpatrick C, Cho E, Lamers Y, Ulrich CM, Reed MC.  A mathematical model gives insights into the effects of vitamin B-6 deficiency on one-carbon and glutathione metabolism.  Journal of Nutrition 2009;139(4): 784-91.
  • Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A, Song X, Ulrich CM, Sasazuki, Shirasawa, Grady WM. TGF-ß receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a ß-catenin-independent pathway. Gastroenterology 2009;136:1680-1688.
  • Curtin K, Samowitz WS, Wolff RK, Caan BJ, Ulrich CM, Potter JD, Slattery ML. MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Molecular Carcinogenesis 2009;48:989-94.
  • Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin F, Makar K, Carlson C, Caan BJ, Potter JD, Peters U. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Epidemiology, Biomarkers and Prevention 2009;18:2540-8.
  • Kong A, Neuhouser ML, Xiao L, Ulrich CM, McTiernan A, Foster-Schubert KE. Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels. Nutrition Research 2009;29:768-776.
  • Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiology, Biomarkers and Prevention 2009;18:3384-3388.
  • Maruti SS, Ulrich CM, Jupe ER, White E. MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Research 2009;11:R91.
  • Thomas DC, Conti DV, Baurley J, Nijhout F, Reed M, Ulrich CM. Use of pathway information in molecular epidemiology. Human Genomics 2009; 4:21-42.
  • Figueiredo JC, Levine JA, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter JD, Limburg PJ, Hopper J, Jenkins MA, LeMarchand L, Baron JA, Haile RW. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes & Control 2010;21:597-608.
  • Siegel EM, Ulrich CM, Poole EM, Holmes R, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions of colorectal cancer prognosis. Cancer Control: Journal of the Moffitt Cancer Center 2010;17:52-57.
  • De Roos AJ, Ulrich CM, Ray RM, Mossavar-Rahmani Y, Rosenberg CA, Caan B, Thomson C, McTiernan A, Lacroix A. Intentional weight loss and risk of lympohematopoietic cancer. Cancer Causes Control 2010; 21:223-36.
    Rundle A, Richie J, Steindorf K, Peluso M, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Tormo M, Quiros JR, Berglund G, Jarvholm B, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Vineis P. Physical activity and lung cancer risk among non-smokers: a pilot molecular epidemiologic study within EPIC. Biomarkers 2010; 15: 20-30.
  • Huerta JM, Navarro C, Chirlaque MD, Tormo MJ, Steindorf K, Buckland G, Carneiro F, Johnsen NF, Overvad K, Stegger J, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Boeing H, Kaaks R, Rohrmann S, Vigl M, Lagiou P, Trichopoulos D, Trichopoulou A, Bas Bueno-de-Mesquita H, Monninkhof EM, Numans ME, Peeters PH, Mattiello A, Pala V, Palli D, Tumino R, Vineis P, Agudo A, Ardanaz E, Arriola L, Molina-Montes E, Rodríguez L, Lindkvist B, Manjer J, Stenling R, Lund E, Crowe FL, Key TJ, Khaw KT, Wareham NJ, Jenab M, Norat T, Romaguera D, Riboli E, González CA. Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort. Cancer Causes Control 2010; 21: 657-669.
  • Schmidt ME, Chang Claude J, Slanger T, Obi N, Flesch Janys D, Steindorf K.  Körperliche Aktivität und postmenopausaler Brustkrebs: Effektmodifikationen durch andere Brustkrebsrisikofaktoren. Onkologische Welt 2010; 1/2010: 3-5.
  • Steindorf K, Flesch Janys D, Chang Claude J, Schmidt ME. Determinants of sports, cycling, walking and overall leisure-time physical activity among postmenopausal women in Germany. Public Health Nutrition 2010; 13: 1905-1914.
  • Poole EM, Hsu L, Xiao L, Kulmacz RJ, Carlson CS, Rabinovitch PS, Potter JD, Ulrich CM. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and risk of colorectal adenoma. Cancer Epidemiology, Biomarkers and Prevention 2010; 19:547-57.
  • Levine AJ, Figueiredo JC, Lee W, Poynter JN, Conti D, Duggan DJ, Campbell PT, Newcomb P, Martinez ME, Hopper JL, LeMarchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW. Genetic Variability in the MTHFR gene and colorectal cancer risk using the Colorectal Cancer Family Registry. Cancer Epidemiology, Biomarkers and Prevention 2010; 19:89-100.
  • Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martinez ME, for the Colon Cancer Family Registry. Case-control study of obesity, overweight and colorectal cancer risk, overall and by tumor microsatellite instability status. Journal of the National Cancer Institute 2010; 102 (6):391-400.
  • Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM. Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 2010; 42(8): 1448-1453.
    Chang JL, Chen G, Ulrich CM, Bigler J, King IB, Schwartz Y, Li S, Potter JD, Lampe JW. DNA damage and repair: fruit and vegetable effects in a feeding trial. Nutrition and Cancer 2010; 62:329-35.
  • Hooper LE, Foster-Schubert KE, Weigle DS, Sorensen B, McTiernan A, Ulrich CM. Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women. Nutrition Research 2010; 30:163-170.
  • Levine AJ, Figueiredo J, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiology, Biomarkers, & Prevention 2010; 19(7): 1812-1821.
  • Holmes RS, Zheng Y, Baron JA, Li L, McKeown-Eyssen G, Newcomb PA, Stern MC, Haile RW, Grady WM, Potter JD, Le Marchand L, Campbell PT,  Figueiredo JC,  Limburg PJ, Jenkins MA, Hopper JL and Ulrich CM. Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention 2010; 19(8): 2023-2024.
  • Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Gallinger S, Baron JA, Adams M, Willis J, Elston R, Markowitz SD, Wiesner GL. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Research 2010; 70(13):5409-5418.
  • George SM, Neuhouser ML, Mayne ST, Irwin ML, Albanes D, Gail MH, Alfano CM, Bernstein L, McTiernan A, Reedy J, Smith AW, Ulrich CM, Ballard-Barbash R. Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2010; 19:2220-8.
  • Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson S, Weinshilboum RM, Ratain MJ, McLeod H, Epstein RS, Ginsburg GS, Schilsky R, Liu G, Flockhart DA, Ulrich CM, Long RM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling M, Rothman N, Xie H, Spitz M, Ballard-Barbash R, Mitnasian L. Cancer Pharmocogenomics and Pharmacoepidemiology: Setting a research agenda to accelerate translation. Journal of the National Cancer Institute 2010; 102:1698-1705.
  • Ulrich CM, Grady WM. Linking epidemiology to epigenomics - where are we today? Cancer Prevention Research 2010 Dec; 3:1505-8.